Term	Accession	Genes (tot)	Stat (non-dir.) p	p adj (non-dir.)	Significant..in.gene.set.	Non.significant..in.gene.set.	Significant..not.in.gene.set.	Non.significant..not.in.gene.set.	effect.size
R-HSA-1059683	Interleukin-6 signaling	 11	0.0699194510472838	1	5	6	2458	8822	2.08374856974126
R-HSA-109606	Intrinsic Pathway for Apoptosis	 29	0.992818086354007	1	2	27	2461	8801	0.316154955409019
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	 49	0.00523077683076685	0.602965911037487	19	30	2444	8798	1.77756510643234
R-HSA-109703	PKB-mediated events	 29	0.630454001273273	1	6	23	2457	8805	0.948464866227057
R-HSA-109704	PI3K Cascade	 47	0.0363268868324988	1	16	31	2447	8797	1.56059467350835
R-HSA-110056	MAPK3 (ERK1) activation	  8	0.244235637590807	1	3	5	2460	8823	1.71909257003654
R-HSA-110312	Translesion synthesis by REV1	 12	0.255573064839343	1	4	8	2459	8820	1.52808228447693
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	 24	0.256727023069242	1	7	17	2456	8811	1.33707199891731
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	 19	0.62120753415347	1	4	15	2459	8813	0.965104600722269
R-HSA-110320	Translesion Synthesis by POLH	 12	0.505047854496056	1	3	9	2460	8819	1.14606171335769
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	  6	0.389152784561032	1	2	4	2461	8824	1.52808228447693
R-HSA-110329	Cleavage of the damaged pyrimidine 	  6	0.389152784561032	1	2	4	2461	8824	1.52808228447693
R-HSA-110357	Displacement of DNA glycosylase by APEX1	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	  5	1	1	0	5	2463	8823	0
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	 17	0.912595190441152	1	2	15	2461	8813	0.53932315922715
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-111447	Activation of BAD and translocation to mitochondria 	 13	1	1	0	13	2463	8815	0
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	  5	1	1	0	5	2463	8823	0
R-HSA-111465	Apoptotic cleavage of cellular proteins	 28	0.0274601377247034	0.924916724049397	11	17	2452	8811	1.80095412099066
R-HSA-111471	Apoptotic factor-mediated response	  5	1	1	0	5	2463	8823	0
R-HSA-111885	Opioid Signalling	 69	0.912618618073789	1	11	58	2452	8770	0.730821962141138
R-HSA-111931	PKA-mediated phosphorylation of CREB	 17	0.525924797189044	1	4	13	2459	8815	1.0786463184543
R-HSA-111933	Calmodulin induced events	 23	0.386525205747609	1	6	17	2457	8811	1.19589048350368
R-HSA-111957	Cam-PDE 1 activation	  5	0.0727556090697057	1	3	2	2460	8826	2.75054811205846
R-HSA-111996	Ca-dependent events	 25	0.472525174770668	1	6	19	2457	8809	1.10021924482339
R-HSA-111997	CaM pathway	 23	0.386525205747609	1	6	17	2457	8811	1.19589048350368
R-HSA-112040	G-protein mediated events	 38	0.753037006301426	1	7	31	2456	8797	0.844466525631985
R-HSA-112043	PLC beta mediated events	 37	0.726430011131693	1	7	30	2456	8798	0.86728994524366
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	  9	1	1	0	9	2463	8819	0
R-HSA-112310	Neurotransmitter Release Cycle	 39	0.882239381755819	1	6	33	2457	8795	0.705268746681658
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-112382	Formation of RNA Pol II elongation complex 	 35	0.0114578152383597	0.695798657803718	14	21	2449	8807	1.83369874137231
R-HSA-112387	Elongation arrest and recovery	 26	0.0935677232464829	1	9	17	2454	8811	1.58685468003373
R-HSA-112409	RAF-independent MAPK1/3 activation	 20	0.449915388525238	1	5	15	2458	8813	1.14606171335769
R-HSA-112411	MAPK1 (ERK2) activation	  9	0.310648370081749	1	3	6	2460	8822	1.52808228447693
R-HSA-113418	Formation of the Early Elongation Complex	 19	0.0376997203887619	1	8	11	2455	8817	1.93020920144454
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	  9	0.111410172608924	1	4	5	2459	8823	2.03744304596923
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	  6	1	1	0	6	2463	8822	0
R-HSA-113510	E2F mediated regulation of DNA replication	 21	0.496629010442084	1	5	16	2458	8812	1.09148734605495
R-HSA-114452	Activation of BH3-only proteins	 21	0.961044201850021	1	2	19	2461	8809	0.436594938421979
R-HSA-114508	Effects of PIP2 hydrolysis	 21	0.961044201850021	1	2	19	2461	8809	0.436594938421979
R-HSA-114604	GPVI-mediated activation cascade	 27	0.870941024335566	1	4	23	2459	8805	0.679147681989745
R-HSA-114608	Platelet degranulation 	 84	0.902910879092597	1	14	70	2449	8758	0.764041142238463
R-HSA-1169091	Activation of NF-kappaB in B cells	 49	0.86766871269874	1	8	41	2455	8787	0.748448465866249
R-HSA-1169092	Activation of RAS in B cells	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-1169408	ISG15 antiviral mechanism	 51	0.812139278182219	1	9	42	2454	8786	0.808984738840725
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	 51	0.812139278182219	1	9	42	2454	8786	0.808984738840725
R-HSA-1170546	Prolactin receptor signaling	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-1181150	Signaling by NODAL	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-1187000	Fertilization	  7	0.180538352594607	1	3	4	2460	8824	1.9646772228989
R-HSA-1221632	Meiotic synapsis	 31	0.698072369751582	1	6	25	2457	8803	0.887273584534989
R-HSA-1222556	ROS, RNS production in phagocytes	 16	0.893609705688787	1	2	14	2461	8814	0.573030856678847
R-HSA-1226099	Signaling by FGFR in disease	 38	0.0248087337900446	0.924916724049397	14	24	2449	8804	1.68893305126397
R-HSA-1227986	Signaling by ERBB2	 37	0.848300228323461	1	6	31	2457	8797	0.743391381637423
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	 55	0.996394002495776	1	5	50	2458	8778	0.416749713948252
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	 49	0.997108671839689	1	4	45	2459	8783	0.374224232933125
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	 13	0.563566823464473	1	3	10	2460	8818	1.05790312002249
R-HSA-1236394	Signaling by ERBB4	 28	0.593524717781401	1	6	22	2457	8806	0.982338611449452
R-HSA-1236974	ER-Phagosome pathway	 62	0.823670474186682	1	11	51	2452	8777	0.813334119157073
R-HSA-1236975	Antigen processing-Cross presentation	 72	0.819632189554512	1	13	59	2450	8769	0.827711237425001
R-HSA-1236977	Endosomal/Vacuolar pathway	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	 36	0.991536016316827	1	3	33	2460	8795	0.382020571119231
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	  6	1	1	0	6	2463	8822	0
R-HSA-1250196	SHC1 events in ERBB2 signaling	 17	0.751218570046053	1	3	14	2460	8814	0.808984738840725
R-HSA-1250342	PI3K events in ERBB4 signaling	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-1250347	SHC1 events in ERBB4 signaling	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-1251985	Nuclear signaling by ERBB4	 16	0.47414729535597	1	4	12	2459	8816	1.14606171335769
R-HSA-1257604	PIP3 activates AKT signaling	 84	0.134907223422334	1	23	61	2440	8767	1.25521044796319
R-HSA-1266695	Interleukin-7 signaling	  8	0.548719530599867	1	2	6	2461	8822	1.14606171335769
R-HSA-1268020	Mitochondrial protein import	 43	0.972316176085079	1	5	38	2458	8790	0.533051959701253
R-HSA-1295596	Spry regulation of FGF signaling	 10	0.377417662941624	1	3	7	2460	8821	1.37527405602923
R-HSA-1296041	Activation of G protein gated Potassium channels	 18	1	1	0	18	2463	8810	0
R-HSA-1296052	Ca2+ activated K+ channels	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-1296059	G protein gated Potassium channels	 18	1	1	0	18	2463	8810	0
R-HSA-1296065	Inwardly rectifying K+ channels	 22	0.995570286437939	1	1	21	2462	8807	0.208374856974126
R-HSA-1296071	Potassium Channels	 66	0.933713692421563	1	10	56	2453	8772	0.694582856580421
R-HSA-1296072	Voltage gated Potassium channels	 30	0.815293153213977	1	5	25	2458	8803	0.764041142238463
R-HSA-1296346	Tandem pore domain potassium channels	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	  5	0.0727556090697057	1	3	2	2460	8826	2.75054811205846
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	  7	0.180538352594607	1	3	4	2460	8824	1.9646772228989
R-HSA-1368082	RORA activates gene expression	 24	0.256727023069242	1	7	17	2456	8811	1.33707199891731
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	 38	0.307047498290941	1	10	28	2453	8800	1.20638075090284
R-HSA-1369062	ABC transporters in lipid homeostasis	 11	0.0699194510472838	1	5	6	2458	8822	2.08374856974126
R-HSA-139853	Elevation of cytosolic Ca2+ levels	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-139915	Activation of PUMA and translocation to mitochondria	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-140342	Apoptosis induced DNA fragmentation	  8	0.548719530599867	1	2	6	2461	8822	1.14606171335769
R-HSA-140534	Ligand-dependent caspase activation	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	 12	1	1	0	12	2463	8816	0
R-HSA-140875	Common Pathway of Fibrin Clot Formation	 11	0.933344122993706	1	1	10	2462	8818	0.416749713948252
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	 18	0.988123330352398	1	1	17	2462	8811	0.254680380746154
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	 12	0.947898504648538	1	1	11	2462	8817	0.382020571119231
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	 12	0.947898504648538	1	1	11	2462	8817	0.382020571119231
R-HSA-1433559	Regulation of KIT signaling	 10	0.377417662941624	1	3	7	2460	8821	1.37527405602923
R-HSA-1442490	Collagen degradation	 32	0.140780878730798	1	10	22	2453	8806	1.43257714169712
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	 51	0.701582767760329	1	10	41	2453	8787	0.89887193204525
R-HSA-1461973	Defensins	  6	1	1	0	6	2463	8822	0
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-1474165	Reproduction	  7	0.180538352594607	1	3	4	2460	8824	1.9646772228989
R-HSA-1474228	Degradation of the extracellular matrix	 75	0.692218816959218	1	15	60	2448	8768	0.916849370686155
R-HSA-1474290	Collagen formation	 54	0.770025549299197	1	10	44	2453	8784	0.848934602487181
R-HSA-1475029	Reversible hydration of carbon dioxide	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-1480926	O2/CO2 exchange in erythrocytes	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-1482788	Acyl chain remodelling of PC	 13	0.133147055374859	1	5	8	2458	8820	1.76317186670414
R-HSA-1482801	Acyl chain remodelling of PS	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-1482839	Acyl chain remodelling of PE	 13	0.133147055374859	1	5	8	2458	8820	1.76317186670414
R-HSA-1482922	Acyl chain remodelling of PI	  8	0.244235637590807	1	3	5	2460	8823	1.71909257003654
R-HSA-1482925	Acyl chain remodelling of PG	  8	0.548719530599867	1	2	6	2461	8822	1.14606171335769
R-HSA-1483115	Hydrolysis of LPC	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-1483148	Synthesis of PG	  8	0.548719530599867	1	2	6	2461	8822	1.14606171335769
R-HSA-1483166	Synthesis of PA	 18	0.786445451613584	1	3	15	2460	8813	0.764041142238463
R-HSA-1483191	Synthesis of PC	 18	0.0766996906860068	1	7	11	2456	8817	1.78276266522308
R-HSA-1483206	Glycerophospholipid biosynthesis	 84	0.197742136593824	1	22	62	2441	8766	1.20063608066044
R-HSA-1483213	Synthesis of PE	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-1483249	Inositol phosphate metabolism	 39	0.882239381755819	1	6	33	2457	8795	0.705268746681658
R-HSA-1483255	PI Metabolism	 55	0.98869117842436	1	6	49	2457	8779	0.500099656737903
R-HSA-1489509	DAG and IP3 signaling	 29	0.630454001273273	1	6	23	2457	8805	0.948464866227057
R-HSA-1500620	Meiosis	 43	0.468428237811108	1	10	33	2453	8795	1.06610391940251
R-HSA-1500931	Cell-Cell communication	 81	0.990234782992684	1	10	71	2453	8757	0.56595640165812
R-HSA-1502540	Signaling by Activin	 10	0.9147261342132	1	1	9	2462	8819	0.458424685343078
R-HSA-1538133	G0 and Early G1	 12	0.947898504648538	1	1	11	2462	8817	0.382020571119231
R-HSA-156580	Phase II conjugation	 39	0.486443500980137	1	9	30	2454	8798	1.05790312002249
R-HSA-156581	Methylation	  9	0.310648370081749	1	3	6	2460	8822	1.52808228447693
R-HSA-156584	Cytosolic sulfonation of small molecules	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-156590	Glutathione conjugation	 20	0.449915388525238	1	5	15	2458	8813	1.14606171335769
R-HSA-1566948	Elastic fibre formation	 24	0.979135854508336	1	2	22	2461	8806	0.382020571119231
R-HSA-1566977	Fibronectin matrix formation	  5	1	1	0	5	2463	8823	0
R-HSA-156711	Polo-like kinase mediated events	  6	1	1	0	6	2463	8822	0
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	 31	0.528963557258349	1	7	24	2456	8804	1.03515251529082
R-HSA-156842	Eukaryotic Translation Elongation	 20	0.449915388525238	1	5	15	2458	8813	1.14606171335769
R-HSA-156902	Peptide chain elongation	 19	0.402121517414399	1	5	14	2458	8814	1.20638075090284
R-HSA-157118	Signaling by NOTCH	 85	0.296721634529635	1	21	64	2442	8764	1.13257863437702
R-HSA-157579	Telomere Maintenance	 35	0.96399250244369	1	4	31	2459	8797	0.523913926106374
R-HSA-157858	Gap junction trafficking and regulation	 28	0.961257537432364	1	3	25	2460	8803	0.491169305724726
R-HSA-15869	Metabolism of nucleotides	 60	0.561789650487249	1	13	47	2450	8781	0.993253484910001
R-HSA-1592230	Mitochondrial biogenesis	 44	0.644857315416143	1	9	35	2454	8793	0.937686856383568
R-HSA-159227	Transport of the SLBP independent Mature mRNA	 26	0.514292771601791	1	6	20	2457	8808	1.05790312002249
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	 27	0.554726114721449	1	6	21	2457	8807	1.01872152298462
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	 32	0.565864121405407	1	7	25	2456	8803	1.00280399918798
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	 33	0.601373291225003	1	7	26	2456	8802	0.972415999212589
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	 51	0.00362825046383879	0.602965911037487	20	31	2443	8797	1.7977438640905
R-HSA-1592389	Activation of Matrix Metalloproteinases	 14	0.968169651082891	1	1	13	2462	8815	0.327446203816484
R-HSA-159418	Recycling of bile acids and salts	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-159740	Gamma-carboxylation of protein precursors	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	 18	0.575084162208403	1	4	14	2459	8814	1.01872152298462
R-HSA-1614558	Degradation of cysteine and homocysteine	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-1614635	Sulfur amino acid metabolism	 18	0.353867019621291	1	5	13	2458	8815	1.27340190373077
R-HSA-162587	HIV Life Cycle	 95	0.240513732081805	1	24	71	2439	8757	1.15812552086672
R-HSA-162588	Budding and maturation of HIV virion	 14	0.171703854694588	1	5	9	2458	8819	1.63723101908242
R-HSA-162592	Integration of provirus	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-162594	Early Phase of HIV Life Cycle	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-162599	Late Phase of HIV Life Cycle	 86	0.232734566844876	1	22	64	2441	8764	1.17271431134276
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	 13	0.959275930222671	1	1	12	2462	8816	0.352634373340829
R-HSA-162791	Attachment of GPI anchor to uPAR	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-162909	Host Interactions of HIV factors	 97	0.987558151624083	1	13	84	2450	8744	0.614383598913403
R-HSA-1630316	Glycosaminoglycan metabolism	 82	0.962039396958566	1	12	70	2451	8758	0.670865393184992
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	 51	0.999602811174644	1	3	48	2460	8780	0.269661579613575
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	 76	0.926121236833302	1	12	64	2451	8764	0.723828450541701
R-HSA-163210	Formation of ATP by chemiosmotic coupling	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-1632852	Macroautophagy	 51	0.571904397256592	1	11	40	2452	8788	0.988759125249775
R-HSA-163359	Glucagon signaling in metabolic regulation	 26	0.850434814350682	1	4	22	2459	8806	0.705268746681658
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	 13	0.959275930222671	1	1	12	2462	8816	0.352634373340829
R-HSA-163615	PKA activation	 16	0.47414729535597	1	4	12	2459	8816	1.14606171335769
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	  7	0.180538352594607	1	3	4	2460	8824	1.9646772228989
R-HSA-163685	Integration of energy metabolism	 87	0.959405462472747	1	13	74	2450	8754	0.685002403386208
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-1638074	Keratan sulfate/keratin metabolism	 24	0.920750359086427	1	3	21	2460	8807	0.573030856678847
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	 38	0.939765763925013	1	5	33	2458	8795	0.603190375451418
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	 20	0.664030570560528	1	4	16	2459	8812	0.916849370686155
R-HSA-1643713	Signaling by EGFR in Cancer	 13	0.563566823464473	1	3	10	2460	8818	1.05790312002249
R-HSA-164378	PKA activation in glucagon signalling	 15	0.420343931222697	1	4	11	2459	8817	1.22246582758154
R-HSA-164843	2-LTR circle formation	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	 14	0.617640430073683	1	3	11	2460	8817	0.982338611449452
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	  6	0.122356109046401	1	3	3	2460	8825	2.29212342671539
R-HSA-164944	Nef and signal transduction	  5	1	1	0	5	2463	8823	0
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	 19	0.817427561137355	1	3	16	2460	8812	0.723828450541701
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	 28	0.762741365449813	1	5	23	2458	8805	0.81861550954121
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	 42	0.920992330344259	1	6	36	2457	8792	0.654892407632968
R-HSA-165159	mTOR signalling	 29	0.630454001273273	1	6	23	2457	8805	0.948464866227057
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	 43	0.0682505684775124	1	14	29	2449	8799	1.49254548716351
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	 88	0.562283004386581	1	19	69	2444	8759	0.989780570627099
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	 35	0.96399250244369	1	4	31	2459	8797	0.523913926106374
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	 13	0.563566823464473	1	3	10	2460	8818	1.05790312002249
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	 14	0.617640430073683	1	3	11	2460	8817	0.982338611449452
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-166054	Activated TLR4 signalling	 80	0.484588450142343	1	18	62	2445	8766	1.03145554202192
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	 67	0.72909677288678	1	13	54	2450	8774	0.889480732755225
R-HSA-1660661	Sphingolipid de novo biosynthesis	 30	0.490903478967701	1	7	23	2456	8805	1.06965759913385
R-HSA-1660662	Glycosphingolipid metabolism	 28	0.762741365449813	1	5	23	2458	8805	0.81861550954121
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade 	 73	0.319605777468988	1	18	55	2445	8773	1.13036223783225
R-HSA-166208	mTORC1-mediated signalling	 16	0.893609705688787	1	2	14	2461	8814	0.573030856678847
R-HSA-1663150	The activation of arylsulfatases	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-166658	Complement cascade	 23	0.905794890457623	1	3	20	2460	8808	0.59794524175184
R-HSA-166663	Initial triggering of complement	 15	1	1	0	15	2463	8813	0
R-HSA-166786	Creation of C4 and C2 activators	 10	1	1	0	10	2463	8818	0
R-HSA-167021	PLC-gamma1 signalling	 31	0.698072369751582	1	6	25	2457	8803	0.887273584534989
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	 25	0.0751467060398408	1	9	16	2454	8812	1.65032886723508
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	 19	0.0376997203887619	1	8	11	2455	8817	1.93020920144454
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	 15	0.213917686252712	1	5	10	2458	8818	1.52808228447693
R-HSA-167161	HIV Transcription Initiation	 31	0.360411781971192	1	8	23	2455	8805	1.18303144604665
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	 31	0.360411781971192	1	8	23	2455	8805	1.18303144604665
R-HSA-167169	HIV Transcription Elongation	 24	0.132629884165308	1	8	16	2455	8812	1.52808228447693
R-HSA-167172	Transcription of the HIV genome	 43	0.212480356336641	1	12	31	2451	8797	1.27932470328301
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	 24	0.132629884165308	1	8	16	2455	8812	1.52808228447693
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	 15	0.66696455478643	1	3	12	2460	8816	0.916849370686155
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	 12	0.255573064839343	1	4	8	2459	8820	1.52808228447693
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	 15	0.66696455478643	1	3	12	2460	8816	0.916849370686155
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	 24	0.132629884165308	1	8	16	2455	8812	1.52808228447693
R-HSA-167287	HIV elongation arrest and recovery	 16	0.47414729535597	1	4	12	2459	8816	1.14606171335769
R-HSA-167290	Pausing and recovery of HIV elongation	 16	0.47414729535597	1	4	12	2459	8816	1.14606171335769
R-HSA-167590	Nef Mediated CD4 Down-regulation	  8	1	1	0	8	2463	8820	0
R-HSA-1679131	Trafficking and processing of endosomal TLR	  8	0.244235637590807	1	3	5	2460	8823	1.71909257003654
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	 70	0.786488854961938	1	13	57	2450	8771	0.851360129922858
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	 61	0.705662574983708	1	12	49	2451	8779	0.901819053133923
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	 73	0.319605777468988	1	18	55	2445	8773	1.13036223783225
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	 61	0.705662574983708	1	12	49	2451	8779	0.901819053133923
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	 67	0.72909677288678	1	13	54	2450	8774	0.889480732755225
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	 66	0.707930522840256	1	13	53	2450	8775	0.902957713554547
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	 67	0.72909677288678	1	13	54	2450	8774	0.889480732755225
R-HSA-168253	Host Interactions with Influenza Factors	 31	0.528963557258349	1	7	24	2456	8804	1.03515251529082
R-HSA-168254	Influenza Infection	 66	0.595461336202515	1	14	52	2449	8776	0.972415999212589
R-HSA-168255	Influenza Life Cycle	 59	0.658393023706116	1	12	47	2451	8781	0.932389190528293
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	 24	0.625675295486514	1	5	19	2458	8809	0.955051427798078
R-HSA-168273	Influenza Viral RNA Transcription and Replication	 51	0.571904397256592	1	11	40	2452	8788	0.988759125249775
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	 26	0.699598552823495	1	5	21	2458	8807	0.881585933352072
R-HSA-168276	 NS1 Mediated Effects on Host Pathways	 29	0.45196246439589	1	7	22	2456	8806	1.10654234393157
R-HSA-168325	Viral Messenger RNA Synthesis	 30	0.665341631849666	1	6	24	2457	8804	0.916849370686155
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	 25	0.663962825665475	1	5	20	2458	8808	0.916849370686155
R-HSA-168638	NOD1/2 Signaling Pathway	 19	0.402121517414399	1	5	14	2458	8814	1.20638075090284
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	 29	0.630454001273273	1	6	23	2457	8805	0.948464866227057
R-HSA-168799	Neurotoxicity of clostridium toxins	 10	1	1	0	10	2463	8818	0
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	 52	0.725720283469877	1	10	42	2453	8786	0.881585933352072
R-HSA-169911	Regulation of Apoptosis	 37	0.993047612089271	1	3	34	2460	8794	0.371695690818712
R-HSA-170660	Adenylate cyclase activating pathway	 10	0.9147261342132	1	1	9	2462	8819	0.458424685343078
R-HSA-170670	Adenylate cyclase inhibitory pathway	 13	0.811369397758936	1	2	11	2461	8817	0.705268746681658
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	 24	0.625675295486514	1	5	19	2458	8809	0.955051427798078
R-HSA-170834	Signaling by TGF-beta Receptor Complex	 54	0.770025549299197	1	10	44	2453	8784	0.848934602487181
R-HSA-171007	p38MAPK events	 10	0.9147261342132	1	1	9	2462	8819	0.458424685343078
R-HSA-171052	LDL-mediated lipid transport	 14	0.843657559039812	1	2	12	2461	8816	0.654892407632968
R-HSA-171306	Packaging Of Telomere Ends	 17	0.912595190441152	1	2	15	2461	8813	0.53932315922715
R-HSA-173623	Classical antibody-mediated complement activation	  8	1	1	0	8	2463	8820	0
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	 11	0.933344122993706	1	1	10	2462	8818	0.416749713948252
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	 43	0.997915278362992	1	3	40	2460	8788	0.319831175820752
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	 37	0.993047612089271	1	3	34	2460	8794	0.371695690818712
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	 54	0.995693745762011	1	5	49	2458	8779	0.42446730124359
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	 45	0.993886339880301	1	4	41	2459	8787	0.407488609193847
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	 46	0.983023638773844	1	5	41	2458	8787	0.498287701459867
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	 48	0.996507256367889	1	4	44	2459	8784	0.382020571119231
R-HSA-174403	Glutathione synthesis and recycling	  9	0.111410172608924	1	4	5	2459	8823	2.03744304596923
R-HSA-174411	Polymerase switching on the C-strand of the telomere	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-174414	Processive synthesis on the C-strand of the telomere	  7	1	1	0	7	2463	8821	0
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	 16	0.893609705688787	1	2	14	2461	8814	0.573030856678847
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	  7	1	1	0	7	2463	8821	0
R-HSA-174800	Chylomicron-mediated lipid transport	 13	0.563566823464473	1	3	10	2460	8818	1.05790312002249
R-HSA-174824	Lipoprotein metabolism	 42	0.840758756497973	1	7	35	2456	8793	0.764041142238463
R-HSA-175474	Assembly Of The HIV Virion	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-176033	Interactions of Vpr with host cellular proteins	 29	0.630454001273273	1	6	23	2457	8805	0.948464866227057
R-HSA-176187	Activation of ATR in response to replication stress	 22	0.968316004721824	1	2	20	2461	8808	0.416749713948252
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	 10	0.9147261342132	1	1	9	2462	8819	0.458424685343078
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	 52	0.998370447775651	1	4	48	2459	8780	0.352634373340829
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	 50	0.997609181133935	1	4	46	2459	8782	0.366739748274462
R-HSA-176412	Phosphorylation of the APC/C	 11	0.933344122993706	1	1	10	2462	8818	0.416749713948252
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	 50	0.997609181133935	1	4	46	2459	8782	0.366739748274462
R-HSA-176974	Unwinding of DNA	  6	1	1	0	6	2463	8822	0
R-HSA-177243	Interactions of Rev with host cellular proteins	 29	0.790301232986592	1	5	24	2458	8804	0.790387388522548
R-HSA-177504	Retrograde neurotrophin signalling	 14	0.968169651082891	1	1	13	2462	8815	0.327446203816484
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	 34	0.957417502726976	1	4	30	2459	8798	0.53932315922715
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	 12	0.947898504648538	1	1	11	2462	8817	0.382020571119231
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	 48	0.996507256367889	1	4	44	2459	8784	0.382020571119231
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	 35	0.0114578152383597	0.695798657803718	14	21	2449	8807	1.83369874137231
R-HSA-180024	DARPP-32 events	 23	0.220532024222261	1	7	16	2456	8812	1.39520556408763
R-HSA-180292	GAB1 signalosome	 86	0.109027385774517	1	24	62	2439	8766	1.27932470328301
R-HSA-180534	Vpu mediated degradation of CD4	 37	0.993047612089271	1	3	34	2460	8794	0.371695690818712
R-HSA-180585	Vif-mediated degradation of APOBEC3G	 38	0.978479754460976	1	4	34	2459	8794	0.482552300361134
R-HSA-180746	Nuclear import of Rev protein	 26	0.699598552823495	1	5	21	2458	8807	0.881585933352072
R-HSA-180786	Extension of Telomeres	 18	0.928363907794598	1	2	16	2461	8812	0.509360761492308
R-HSA-180910	Vpr-mediated nuclear import of PICs	 26	0.514292771601791	1	6	20	2457	8808	1.05790312002249
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	 15	0.66696455478643	1	3	12	2460	8816	0.916849370686155
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	 15	0.870841098155717	1	2	13	2461	8815	0.61123291379077
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	 16	0.893609705688787	1	2	14	2461	8814	0.573030856678847
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	 67	0.72909677288678	1	13	54	2450	8774	0.889480732755225
R-HSA-182218	Nef Mediated CD8 Down-regulation	  6	1	1	0	6	2463	8822	0
R-HSA-182971	EGFR downregulation	 18	0.18107924081916	1	6	12	2457	8816	1.52808228447693
R-HSA-1834941	STING mediated induction of host immune responses	 10	0.9147261342132	1	1	9	2462	8819	0.458424685343078
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA 	 48	0.749223077971957	1	9	39	2454	8789	0.85954628501827
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	 14	0.171703854694588	1	5	9	2458	8819	1.63723101908242
R-HSA-1839124	FGFR1 mutant receptor activation	 20	0.0511541104256574	1	8	12	2455	8816	1.83369874137231
R-HSA-1839126	FGFR2 mutant receptor activation	 13	0.133147055374859	1	5	8	2458	8820	1.76317186670414
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	 22	0.968316004721824	1	2	20	2461	8808	0.416749713948252
R-HSA-186712	Regulation of beta-cell development	 13	0.959275930222671	1	1	12	2462	8816	0.352634373340829
R-HSA-187015	Activation of TRKA receptors	  5	1	1	0	5	2463	8823	0
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	 43	0.997915278362992	1	3	40	2460	8788	0.319831175820752
R-HSA-189200	Hexose transport	 32	0.565864121405407	1	7	25	2456	8803	1.00280399918798
R-HSA-189445	Metabolism of porphyrins	 10	0.9147261342132	1	1	9	2462	8819	0.458424685343078
R-HSA-189451	Heme biosynthesis	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-190236	Signaling by FGFR	 48	0.00963090338580812	0.695798657803718	18	30	2445	8798	1.71909257003654
R-HSA-190241	FGFR2 ligand binding and activation	  5	0.0727556090697057	1	3	2	2460	8826	2.75054811205846
R-HSA-190242	FGFR1 ligand binding and activation	  5	0.0093303606290775	0.695798657803718	4	1	2459	8827	3.66739748274462
R-HSA-190373	FGFR1c ligand binding and activation	  5	0.0093303606290775	0.695798657803718	4	1	2459	8827	3.66739748274462
R-HSA-190828	Gap junction trafficking	 27	0.95351290493781	1	3	24	2460	8804	0.509360761492308
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	  9	1	1	0	9	2463	8819	0
R-HSA-190861	Gap junction assembly	 17	0.98480336243252	1	1	16	2462	8812	0.269661579613575
R-HSA-190872	Transport of connexons to the plasma membrane	 10	1	1	0	10	2463	8818	0
R-HSA-190873	Gap junction degradation	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	  5	1	1	0	5	2463	8823	0
R-HSA-1912408	Pre-NOTCH Transcription and Translation	 23	0.045482723048181	1	9	14	2454	8814	1.79383572525552
R-HSA-1912420	Pre-NOTCH Processing in Golgi	 13	0.811369397758936	1	2	11	2461	8817	0.705268746681658
R-HSA-1912422	Pre-NOTCH Expression and Processing	 33	0.0859687412813056	1	11	22	2452	8806	1.52808228447693
R-HSA-191273	Cholesterol biosynthesis	 19	0.402121517414399	1	5	14	2458	8814	1.20638075090284
R-HSA-191859	snRNP Assembly	 36	0.541594800681954	1	8	28	2455	8800	1.01872152298462
R-HSA-192105	Synthesis of bile acids and bile salts	 18	0.18107924081916	1	6	12	2457	8816	1.52808228447693
R-HSA-192823	Viral mRNA Translation	 19	0.402121517414399	1	5	14	2458	8814	1.20638075090284
R-HSA-193048	Androgen biosynthesis	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	 11	0.203387011900948	1	4	7	2459	8821	1.66699885579301
R-HSA-193634	Axonal growth inhibition (RHOA activation)	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-193639	p75NTR signals via NF-kB	 11	0.933344122993706	1	1	10	2462	8818	0.416749713948252
R-HSA-193648	NRAGE signals death through JNK	 37	0.726430011131693	1	7	30	2456	8798	0.86728994524366
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-193692	Regulated proteolysis of p75NTR	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-193697	p75NTR regulates axonogenesis	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-193704	p75 NTR receptor-mediated signalling	 66	0.707930522840256	1	13	53	2450	8775	0.902957713554547
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-194068	Bile acid and bile salt metabolism	 20	0.125454976477568	1	7	13	2456	8815	1.60448639870077
R-HSA-194223	HDL-mediated lipid transport	 10	0.9147261342132	1	1	9	2462	8819	0.458424685343078
R-HSA-194313	VEGF ligand-receptor interactions	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-194441	Metabolism of non-coding RNA	 36	0.541594800681954	1	8	28	2455	8800	1.01872152298462
R-HSA-194840	Rho GTPase cycle	 95	0.322207750500813	1	23	72	2440	8756	1.10987029083061
R-HSA-195253	Degradation of beta-catenin by the destruction complex	 67	0.971097979450505	1	9	58	2454	8770	0.615794353445925
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-196025	Formation of annular gap junctions	 10	0.9147261342132	1	1	9	2462	8819	0.458424685343078
R-HSA-196071	Metabolism of steroid hormones	 16	0.47414729535597	1	4	12	2459	8816	1.14606171335769
R-HSA-196299	Beta-catenin phosphorylation cascade	 16	0.114882150598347	1	6	10	2457	8818	1.71909257003654
R-HSA-1963640	GRB2 events in ERBB2 signaling	 12	0.773245924790558	1	2	10	2461	8818	0.764041142238463
R-HSA-1963642	PI3K events in ERBB2 signaling	 11	0.442679157081878	1	3	8	2460	8820	1.25024914184476
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	 12	0.255573064839343	1	4	8	2459	8820	1.52808228447693
R-HSA-196757	Metabolism of folate and pterines	 12	0.505047854496056	1	3	9	2460	8819	1.14606171335769
R-HSA-196780	Biotin transport and metabolism	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-196783	Coenzyme A biosynthesis	  6	1	1	0	6	2463	8822	0
R-HSA-196807	Nicotinate metabolism	 17	0.146286057441442	1	6	11	2457	8817	1.61796947768145
R-HSA-196836	Vitamin C (ascorbate) metabolism	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	 74	0.1706344865646	1	20	54	2443	8774	1.23898563606237
R-HSA-196854	Metabolism of vitamins and cofactors	100	0.521436769360876	1	22	78	2441	8750	1.00853430775477
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	 18	0.928363907794598	1	2	16	2461	8812	0.509360761492308
R-HSA-197264	Nicotinamide salvaging	 11	0.203387011900948	1	4	7	2459	8821	1.66699885579301
R-HSA-1980143	Signaling by NOTCH1	 60	0.561789650487249	1	13	47	2450	8781	0.993253484910001
R-HSA-1980145	Signaling by NOTCH2	 21	0.496629010442084	1	5	16	2458	8812	1.09148734605495
R-HSA-1980148	Signaling by NOTCH3	  9	0.310648370081749	1	3	6	2460	8822	1.52808228447693
R-HSA-1980150	Signaling by NOTCH4	  9	0.310648370081749	1	3	6	2460	8822	1.52808228447693
R-HSA-198203	PI3K/AKT activation	 87	0.178221354161367	1	23	64	2440	8764	1.21192732906791
R-HSA-198323	AKT phosphorylates targets in the cytosol	 12	1	1	0	12	2463	8816	0
R-HSA-198693	AKT phosphorylates targets in the nucleus	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	 22	0.343222636654039	1	6	16	2457	8812	1.25024914184476
R-HSA-198753	ERK/MAPK targets	 19	0.402121517414399	1	5	14	2458	8814	1.20638075090284
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	 48	0.999895679638445	1	2	46	2461	8782	0.191010285559616
R-HSA-1989781	PPARA activates gene expression	 86	0.232734566844876	1	22	64	2441	8764	1.17271431134276
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	 12	0.947898504648538	1	1	11	2462	8817	0.382020571119231
R-HSA-199418	Negative regulation of the PI3K/AKT network	 57	0.356120027130583	1	14	43	2449	8785	1.12595536750931
R-HSA-199920	CREB phosphorylation	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-199992	trans-Golgi Network Vesicle Budding	 53	0.0975656793898668	1	16	37	2447	8791	1.3839235783942
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	 10	0.9147261342132	1	1	9	2462	8819	0.458424685343078
R-HSA-201451	Signaling by BMP	 20	0.664030570560528	1	4	16	2459	8812	0.916849370686155
R-HSA-201688	WNT mediated activation of DVL	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	 38	0.866162082452592	1	6	32	2457	8796	0.723828450541701
R-HSA-202040	G-protein activation	 20	0.992746348136518	1	1	19	2462	8809	0.229212342671539
R-HSA-202131	Metabolism of nitric oxide	 18	0.575084162208403	1	4	14	2459	8814	1.01872152298462
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	 34	0.470492311086196	1	8	26	2455	8802	1.0786463184543
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-2022854	Keratan sulfate biosynthesis	 20	0.844497618297972	1	3	17	2460	8811	0.687637028014616
R-HSA-2022857	Keratan sulfate degradation	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-2022870	Chondroitin sulfate biosynthesis	 15	0.66696455478643	1	3	12	2460	8816	0.916849370686155
R-HSA-2022923	Dermatan sulfate biosynthesis	 11	0.933344122993706	1	1	10	2462	8818	0.416749713948252
R-HSA-2022928	HS-GAG biosynthesis	 20	0.844497618297972	1	3	17	2460	8811	0.687637028014616
R-HSA-202403	TCR signaling	 74	0.908962498058667	1	12	62	2451	8766	0.743391381637423
R-HSA-2024096	HS-GAG degradation	 14	0.843657559039812	1	2	12	2461	8816	0.654892407632968
R-HSA-2024101	CS/DS degradation	 11	0.933344122993706	1	1	10	2462	8818	0.416749713948252
R-HSA-202424	Downstream TCR signaling	 63	0.907012000865257	1	10	53	2453	8775	0.727658230703298
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	  6	1	1	0	6	2463	8822	0
R-HSA-202433	Generation of second messenger molecules	 15	0.975121690577689	1	1	14	2462	8814	0.305616456895385
R-HSA-202670	ERKs are inactivated	 11	0.442679157081878	1	3	8	2460	8820	1.25024914184476
R-HSA-202733	Cell surface interactions at the vascular wall	 84	0.969966337228847	1	12	72	2451	8756	0.654892407632968
R-HSA-2028269	Signaling by Hippo	 16	1	1	0	16	2463	8812	0
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	 68	0.94758278168299	1	10	58	2453	8770	0.674153949033938
R-HSA-2029481	FCGR activation	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	 48	0.851994481278697	1	8	40	2455	8788	0.764041142238463
R-HSA-2029485	Role of phospholipids in phagocytosis	 18	0.988123330352398	1	1	17	2462	8811	0.254680380746154
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	 21	0.703419172941338	1	4	17	2459	8811	0.873189876843957
R-HSA-203615	eNOS activation	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-203765	eNOS activation and regulation	 18	0.575084162208403	1	4	14	2459	8814	1.01872152298462
R-HSA-203927	MicroRNA (miRNA) biogenesis	 16	0.47414729535597	1	4	12	2459	8816	1.14606171335769
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	 53	0.495607439069555	1	12	41	2451	8787	1.03794268379565
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	 14	0.843657559039812	1	2	12	2461	8816	0.654892407632968
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	 12	0.0990149060241598	1	5	7	2458	8821	1.91010285559616
R-HSA-2046105	Linoleic acid (LA) metabolism	  7	0.180538352594607	1	3	4	2460	8824	1.9646772228989
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	 12	0.0990149060241598	1	5	7	2458	8821	1.91010285559616
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	 46	0.816216527879745	1	8	38	2455	8790	0.797260322335787
R-HSA-205025	NADE modulates death signalling	  6	1	1	0	6	2463	8822	0
R-HSA-205043	NRIF signals cell death from the nucleus	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-209543	p75NTR recruits signalling complexes	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-209560	NF-kB is activated and signals survival	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-209952	Peptide hormone biosynthesis	  6	1	1	0	6	2463	8822	0
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	 21	0.961044201850021	1	2	19	2461	8809	0.436594938421979
R-HSA-210745	Regulation of gene expression in beta cells	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-210990	PECAM1 interactions	  8	0.244235637590807	1	3	5	2460	8823	1.71909257003654
R-HSA-210991	Basigin interactions	 19	0.62120753415347	1	4	15	2459	8813	0.965104600722269
R-HSA-210993	Tie2 Signaling	 12	0.505047854496056	1	3	9	2460	8819	1.14606171335769
R-HSA-211000	Gene Silencing by RNA	 67	0.386696017564942	1	16	51	2447	8777	1.0947455172372
R-HSA-211227	Activation of DNA fragmentation factor	  8	0.548719530599867	1	2	6	2461	8822	1.14606171335769
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	 35	0.989709087019115	1	3	32	2460	8796	0.392935444579781
R-HSA-211859	Biological oxidations	 84	0.943671750318551	1	13	71	2450	8757	0.709466774935715
R-HSA-211897	Cytochrome P450 - arranged by substrate type	 23	0.905794890457623	1	3	20	2460	8808	0.59794524175184
R-HSA-211945	Phase 1 - Functionalization of compounds	 45	0.993886339880301	1	4	41	2459	8787	0.407488609193847
R-HSA-211976	Endogenous sterols	 11	0.442679157081878	1	3	8	2460	8820	1.25024914184476
R-HSA-211981	Xenobiotics	  6	1	1	0	6	2463	8822	0
R-HSA-212165	Epigenetic regulation of gene expression	 76	0.205226477343127	1	20	56	2443	8772	1.20638075090284
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	 39	0.882239381755819	1	6	33	2457	8795	0.705268746681658
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	 22	0.186322896357431	1	7	15	2456	8813	1.45862399881888
R-HSA-212300	PRC2 methylates histones and DNA	 23	0.77186805762775	1	4	19	2459	8809	0.797260322335787
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	 18	0.786445451613584	1	3	15	2460	8813	0.764041142238463
R-HSA-212718	EGFR interacts with phospholipase C-gamma	 30	0.665341631849666	1	6	24	2457	8804	0.916849370686155
R-HSA-2129379	Molecules associated with elastic fibres	 20	0.952183867628503	1	2	18	2461	8810	0.458424685343078
R-HSA-2132295	MHC class II antigen presentation	 75	0.955437924594166	1	11	64	2452	8764	0.672356205169847
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-2142753	Arachidonic acid metabolism	 26	0.986334379353005	1	2	24	2461	8804	0.352634373340829
R-HSA-2142789	Ubiquinol biosynthesis	  6	1	1	0	6	2463	8822	0
R-HSA-2142845	Hyaluronan metabolism	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	 37	0.726430011131693	1	7	30	2456	8798	0.86728994524366
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	  8	0.548719530599867	1	2	6	2461	8822	1.14606171335769
R-HSA-216083	Integrin cell surface interactions	 52	0.725720283469877	1	10	42	2453	8786	0.881585933352072
R-HSA-2160916	Hyaluronan uptake and degradation	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-2161522	Abacavir transport and metabolism	  5	1	1	0	5	2463	8823	0
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-2168880	Scavenging of heme from plasma	  7	1	1	0	7	2463	8821	0
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	 26	0.986334379353005	1	2	24	2461	8804	0.352634373340829
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	 20	0.844497618297972	1	3	17	2460	8811	0.687637028014616
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	 24	0.801106610055997	1	4	20	2459	8808	0.764041142238463
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	  9	1	1	0	9	2463	8819	0
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	 31	0.360411781971192	1	8	23	2455	8805	1.18303144604665
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	 16	0.258933838822878	1	5	11	2458	8817	1.43257714169712
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	 21	0.703419172941338	1	4	17	2459	8811	0.873189876843957
R-HSA-2179392	EGFR Transactivation by Gastrin	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-2187338	Visual phototransduction	 46	0.901604291563448	1	7	39	2456	8789	0.697602782043814
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-2214320	Anchoring fibril formation	 10	0.9147261342132	1	1	9	2462	8819	0.458424685343078
R-HSA-2219528	PI3K/AKT Signaling in Cancer	 54	0.182668556357472	1	15	39	2448	8789	1.27340190373077
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	 32	0.0707002682897537	1	11	21	2452	8807	1.57583485586683
R-HSA-2243919	Crosslinking of collagen fibrils	  8	1	1	0	8	2463	8820	0
R-HSA-2262749	Cellular response to hypoxia	 55	0.996394002495776	1	5	50	2458	8778	0.416749713948252
R-HSA-2299718	Condensation of Prophase Chromosomes	 18	0.353867019621291	1	5	13	2458	8815	1.27340190373077
R-HSA-2408517	SeMet incorporation into proteins	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-2408522	Selenoamino acid metabolism	 37	0.417941696284329	1	9	28	2454	8800	1.11508707245613
R-HSA-2408557	Selenocysteine synthesis	 21	0.300431798391328	1	6	15	2457	8813	1.30978481526594
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	 34	0.10310433457689	1	11	23	2452	8805	1.48313868787466
R-HSA-2428933	SHC-related events triggered by IGF1R	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-2453864	Retinoid cycle disease events	  5	1	1	0	5	2463	8823	0
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	 11	0.933344122993706	1	1	10	2462	8818	0.416749713948252
R-HSA-2465910	MASTL Facilitates Mitotic Progression	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-2470946	Cohesin Loading onto Chromatin	 10	0.154853353408707	1	4	6	2459	8822	1.83369874137231
R-HSA-2474795	Diseases associated with visual transduction	  5	1	1	0	5	2463	8823	0
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	 64	0.957406366929302	1	9	55	2454	8773	0.644659713763703
R-HSA-2514853	Condensation of Prometaphase Chromosomes	  5	0.0727556090697057	1	3	2	2460	8826	2.75054811205846
R-HSA-2514856	The phototransduction cascade	 15	0.420343931222697	1	4	11	2459	8817	1.22246582758154
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	 15	0.420343931222697	1	4	11	2459	8817	1.22246582758154
R-HSA-2559580	Oxidative Stress Induced Senescence	 55	0.203449813236011	1	15	40	2448	8788	1.25024914184476
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	 47	0.995785591179466	1	4	43	2459	8785	0.390148668377087
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-2559585	Oncogene Induced Senescence	 20	0.125454976477568	1	7	13	2456	8815	1.60448639870077
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	 33	0.876142269754066	1	5	28	2458	8800	0.694582856580421
R-HSA-2562578	TRIF-mediated programmed cell death	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	 60	0.0492158653504834	1	19	41	2444	8787	1.45167817025308
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	 48	0.621637436769926	1	10	38	2453	8790	0.955051427798078
R-HSA-2644603	Signaling by NOTCH1 in Cancer	 48	0.621637436769926	1	10	38	2453	8790	0.955051427798078
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	  5	1	1	0	5	2463	8823	0
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	 48	0.621637436769926	1	10	38	2453	8790	0.955051427798078
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	  5	1	1	0	5	2463	8823	0
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	 13	0.959275930222671	1	1	12	2462	8816	0.352634373340829
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	 11	0.203387011900948	1	4	7	2459	8821	1.66699885579301
R-HSA-264876	Insulin processing	 24	0.256727023069242	1	7	17	2456	8811	1.33707199891731
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	  7	0.180538352594607	1	3	4	2460	8824	1.9646772228989
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	  7	0.180538352594607	1	3	4	2460	8824	1.9646772228989
R-HSA-2672351	Stimuli-sensing channels	 60	0.0261772072709171	0.924916724049397	20	40	2443	8788	1.52808228447693
R-HSA-2682334	EPH-Ephrin signaling	 70	0.980668754391132	1	9	61	2454	8767	0.589403166869671
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	 11	0.442679157081878	1	3	8	2460	8820	1.25024914184476
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	 11	0.442679157081878	1	3	8	2460	8820	1.25024914184476
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	 91	0.175200594385614	1	24	67	2439	8761	1.20903213716856
R-HSA-2871809	FCERI mediated Ca+2 mobilization	 21	0.868010692524077	1	3	18	2460	8810	0.654892407632968
R-HSA-2871837	FCERI mediated NF-kB activation	 59	0.857913973065733	1	10	49	2453	8779	0.776990992106911
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	 48	0.621637436769926	1	10	38	2453	8790	0.955051427798078
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	 48	0.621637436769926	1	10	38	2453	8790	0.955051427798078
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	 14	0.365296932564035	1	4	10	2459	8818	1.30978481526594
R-HSA-2980736	Peptide hormone metabolism	 51	0.571904397256592	1	11	40	2452	8788	0.988759125249775
R-HSA-2980766	Nuclear Envelope Breakdown	 39	0.486443500980137	1	9	30	2454	8798	1.05790312002249
R-HSA-2990846	SUMOylation	 68	0.30458830493733	1	17	51	2446	8777	1.14606171335769
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-2995410	Nuclear Envelope Reassembly	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-3000157	Laminin interactions	 23	0.77186805762775	1	4	19	2459	8809	0.797260322335787
R-HSA-3000170	Syndecan interactions	 20	0.125454976477568	1	7	13	2456	8815	1.60448639870077
R-HSA-3000171	Non-integrin membrane-ECM interactions	 45	0.795989042207588	1	8	37	2455	8791	0.814977218387693
R-HSA-3000178	ECM proteoglycans	 46	0.901604291563448	1	7	39	2456	8789	0.697602782043814
R-HSA-3000480	Scavenging by Class A Receptors	 13	0.959275930222671	1	1	12	2462	8816	0.352634373340829
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	 53	0.162987474909354	1	15	38	2448	8790	1.29742835474456
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	 65	0.237834973289927	1	17	48	2446	8780	1.19895686935882
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production 	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-3214815	HDACs deacetylate histones	 32	0.996258400891868	1	2	30	2461	8798	0.286515428339423
R-HSA-3214841	PKMTs methylate histone lysines	 35	0.349133541370563	1	9	26	2454	8802	1.17880633373934
R-HSA-3214842	HDMs demethylate histones	 23	0.77186805762775	1	4	19	2459	8809	0.797260322335787
R-HSA-3214847	HATs acetylate histones	 73	0.648776022784223	1	15	58	2448	8770	0.941968531526872
R-HSA-3214858	RMTs methylate histone arginines	 31	0.360411781971192	1	8	23	2455	8805	1.18303144604665
R-HSA-3215018	Processing and activation of SUMO	  5	1	1	0	5	2463	8823	0
R-HSA-3232118	SUMOylation of transcription factors	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-3238698	WNT ligand biogenesis and trafficking	  8	0.548719530599867	1	2	6	2461	8822	1.14606171335769
R-HSA-3270619	IRF3-mediated induction of type I IFN	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-3295583	TRP channels	 11	0.203387011900948	1	4	7	2459	8821	1.66699885579301
R-HSA-3296469	Defects in cobalamin (B12) metabolism	  7	0.180538352594607	1	3	4	2460	8824	1.9646772228989
R-HSA-3296482	Defects in vitamin and cofactor metabolism	 11	0.0699194510472838	1	5	6	2458	8822	2.08374856974126
R-HSA-3299685	Detoxification of Reactive Oxygen Species	 23	0.77186805762775	1	4	19	2459	8809	0.797260322335787
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	 27	0.554726114721449	1	6	21	2457	8807	1.01872152298462
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-3322077	Glycogen synthesis	  8	0.548719530599867	1	2	6	2461	8822	1.14606171335769
R-HSA-3371378	Regulation by c-FLIP	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	 63	0.907012000865257	1	10	53	2453	8775	0.727658230703298
R-HSA-3371511	HSF1 activation	 22	0.968316004721824	1	2	20	2461	8808	0.416749713948252
R-HSA-3371556	Cellular response to heat stress	 79	0.905744809607721	1	13	66	2450	8762	0.754369735374685
R-HSA-3371568	Attenuation phase	 19	0.990718224111117	1	1	18	2462	8810	0.241276150180567
R-HSA-3371571	HSF1-dependent transactivation	 27	0.998709570355621	1	1	26	2462	8802	0.169786920497436
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	 36	0.969612864744289	1	4	32	2459	8796	0.509360761492308
R-HSA-350054	Notch-HLH transcription pathway	 11	0.442679157081878	1	3	8	2460	8820	1.25024914184476
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	 39	0.995326194352807	1	3	36	2460	8792	0.352634373340829
R-HSA-351202	Metabolism of polyamines	 60	0.999941685452777	1	3	57	2460	8771	0.229212342671539
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	  7	1	1	0	7	2463	8821	0
R-HSA-352230	Amino acid transport across the plasma membrane	 20	0.844497618297972	1	3	17	2460	8811	0.687637028014616
R-HSA-354192	Integrin alphaIIb beta3 signaling	 16	0.711460845424228	1	3	13	2460	8815	0.85954628501827
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins 	  8	0.548719530599867	1	2	6	2461	8822	1.14606171335769
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	 18	0.786445451613584	1	3	15	2460	8813	0.764041142238463
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	 14	0.843657559039812	1	2	12	2461	8816	0.654892407632968
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	 14	0.843657559039812	1	2	12	2461	8816	0.654892407632968
R-HSA-3595172	Defective CHST3 causes SEDCJD	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-3595177	Defective CHSY1 causes TPBS	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-3656237	Defective EXT2 causes exostoses 2	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-373080	Class B/2 (Secretin family receptors)	 47	0.961169951393572	1	6	41	2457	8787	0.585223002565631
R-HSA-373752	Netrin-1 signaling	 32	0.397175828161712	1	8	24	2455	8804	1.14606171335769
R-HSA-373753	Nephrin interactions	 15	0.870841098155717	1	2	13	2461	8815	0.61123291379077
R-HSA-373755	Semaphorin interactions	 53	0.998656703045655	1	4	49	2459	8779	0.345980894598549
R-HSA-373760	L1CAM interactions	 83	0.83160958016778	1	15	68	2448	8760	0.828478347005562
R-HSA-375170	CDO in myogenesis	 19	0.218754425800588	1	6	13	2457	8815	1.4476569010834
R-HSA-375276	Peptide ligand-binding receptors	 75	0.999984289794059	1	4	71	2459	8757	0.244493165516308
R-HSA-375280	Amine ligand-binding receptors	 18	0.988123330352398	1	1	17	2462	8811	0.254680380746154
R-HSA-376172	DSCAM interactions	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-376176	Signaling by Robo receptor	 24	0.256727023069242	1	7	17	2456	8811	1.33707199891731
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	 28	0.998991737278038	1	1	27	2462	8801	0.163723101908242
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-3781865	Diseases of glycosylation	 42	0.967530732116071	1	5	37	2458	8791	0.545743673027473
R-HSA-379716	Cytosolic tRNA aminoacylation	 21	0.961044201850021	1	2	19	2461	8809	0.436594938421979
R-HSA-379724	tRNA Aminoacylation	 32	0.728581965523776	1	6	26	2457	8802	0.85954628501827
R-HSA-379726	Mitochondrial tRNA aminoacylation	 14	0.365296932564035	1	4	10	2459	8818	1.30978481526594
R-HSA-380108	Chemokine receptors bind chemokines	 19	0.990718224111117	1	1	18	2462	8810	0.241276150180567
R-HSA-380259	Loss of Nlp from mitotic centrosomes	 50	0.0152471663330298	0.743592573472376	18	32	2445	8796	1.65032886723508
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	 61	0.0573701090941135	1	19	42	2444	8786	1.42788016746204
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	 50	0.0152471663330298	0.743592573472376	18	32	2445	8796	1.65032886723508
R-HSA-380287	Centrosome maturation	 61	0.0573701090941135	1	19	42	2444	8786	1.42788016746204
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	 17	0.912595190441152	1	2	15	2461	8813	0.53932315922715
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	 21	0.496629010442084	1	5	16	2458	8812	1.09148734605495
R-HSA-380994	ATF4 activates genes	 21	0.703419172941338	1	4	17	2459	8811	0.873189876843957
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	 10	0.0462454014092495	1	5	5	2458	8823	2.29212342671539
R-HSA-381038	XBP1(S) activates chaperone genes	 39	0.640123040662939	1	8	31	2455	8797	0.940358328908877
R-HSA-381042	PERK regulates gene expression	 24	0.801106610055997	1	4	20	2459	8808	0.764041142238463
R-HSA-381070	IRE1alpha activates chaperones	 40	0.670160343155598	1	8	32	2455	8796	0.916849370686155
R-HSA-381119	Unfolded Protein Response (UPR)	 67	0.620009176493158	1	14	53	2449	8775	0.95790232758255
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	  8	0.0743762109342742	1	4	4	2459	8824	2.29212342671539
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	 66	0.707930522840256	1	13	53	2450	8775	0.902957713554547
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	 14	0.968169651082891	1	1	13	2462	8815	0.327446203816484
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	 34	0.957417502726976	1	4	30	2459	8798	0.53932315922715
R-HSA-381753	Olfactory Signaling Pathway	 12	0.773245924790558	1	2	10	2461	8818	0.764041142238463
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-382556	ABC-family proteins mediated transport	 69	0.327999011916789	1	17	52	2446	8776	1.12945212330903
R-HSA-383280	Nuclear Receptor transcription pathway	 27	0.554726114721449	1	6	21	2457	8807	1.01872152298462
R-HSA-388841	Costimulation by the CD28 family	 40	0.670160343155598	1	8	32	2455	8796	0.916849370686155
R-HSA-389356	CD28 co-stimulation	 20	0.664030570560528	1	4	16	2459	8812	0.916849370686155
R-HSA-389357	CD28 dependent PI3K/Akt signaling	 13	0.563566823464473	1	3	10	2460	8818	1.05790312002249
R-HSA-389359	CD28 dependent Vav1 pathway	  7	1	1	0	7	2463	8821	0
R-HSA-389513	CTLA4 inhibitory signaling	 18	0.18107924081916	1	6	12	2457	8816	1.52808228447693
R-HSA-389661	Glyoxylate metabolism and glycine degradation	 15	0.870841098155717	1	2	13	2461	8815	0.61123291379077
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-389948	PD-1 signaling	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	 20	0.992746348136518	1	1	19	2462	8809	0.229212342671539
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	 20	0.992746348136518	1	1	19	2462	8809	0.229212342671539
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	 17	1	1	0	17	2463	8811	0
R-HSA-389977	Post-chaperonin tubulin folding pathway	 13	1	1	0	13	2463	8815	0
R-HSA-390247	Beta-oxidation of very long chain fatty acids	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-390450	Folding of actin by CCT/TriC	 10	1	1	0	10	2463	8818	0
R-HSA-390466	Chaperonin-mediated protein folding	 61	0.938195838162578	1	9	52	2454	8776	0.676364289850442
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	 28	0.888974300816525	1	4	24	2459	8804	0.654892407632968
R-HSA-390522	Striated Muscle Contraction	 13	0.959275930222671	1	1	12	2462	8816	0.352634373340829
R-HSA-390666	Serotonin receptors	  6	1	1	0	6	2463	8822	0
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	 24	0.979135854508336	1	2	22	2461	8806	0.382020571119231
R-HSA-390918	Peroxisomal lipid metabolism	 17	0.525924797189044	1	4	13	2459	8815	1.0786463184543
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-391251	Protein folding	 66	0.967055345611121	1	9	57	2454	8771	0.625124570922378
R-HSA-391903	Eicosanoid ligand-binding receptors	  5	1	1	0	5	2463	8823	0
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	 15	0.213917686252712	1	5	10	2458	8818	1.52808228447693
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	 17	0.98480336243252	1	1	16	2462	8812	0.269661579613575
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	 28	0.991091063450363	1	2	26	2461	8802	0.327446203816484
R-HSA-392517	Rap1 signalling	 13	0.811369397758936	1	2	11	2461	8817	0.705268746681658
R-HSA-392518	Signal amplification	 24	0.625675295486514	1	5	19	2458	8809	0.955051427798078
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	 14	0.968169651082891	1	1	13	2462	8815	0.327446203816484
R-HSA-3928662	EPHB-mediated forward signaling	 34	0.957417502726976	1	4	30	2459	8798	0.53932315922715
R-HSA-3928663	EPHA-mediated growth cone collapse	 24	0.801106610055997	1	4	20	2459	8808	0.764041142238463
R-HSA-3928664	Ephrin signaling	 11	0.933344122993706	1	1	10	2462	8818	0.416749713948252
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	 33	0.876142269754066	1	5	28	2458	8800	0.694582856580421
R-HSA-397795	G-protein beta:gamma signalling	 30	0.994215917012967	1	2	28	2461	8800	0.305616456895385
R-HSA-399719	Trafficking of AMPA receptors	 27	0.95351290493781	1	3	24	2460	8804	0.509360761492308
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	 27	0.95351290493781	1	3	24	2460	8804	0.509360761492308
R-HSA-399954	Sema3A PAK dependent Axon repulsion	 13	1	1	0	13	2463	8815	0
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	 11	0.933344122993706	1	1	10	2462	8818	0.416749713948252
R-HSA-399956	CRMPs in Sema3A signaling	 13	1	1	0	13	2463	8815	0
R-HSA-399997	Acetylcholine regulates insulin secretion	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	 23	0.996538463250731	1	1	22	2462	8806	0.199315080583947
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	 88	0.270207628618905	1	22	66	2441	8762	1.14606171335769
R-HSA-400253	Circadian Clock	 54	0.394810241682503	1	13	41	2450	8787	1.10361498323333
R-HSA-400451	Free fatty acids regulate insulin secretion	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-400508	Incretin synthesis, secretion, and inactivation	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-400685	Sema4D in semaphorin signaling	 22	0.968316004721824	1	2	20	2461	8808	0.416749713948252
R-HSA-4085001	Sialic acid metabolism	 25	0.983103907982586	1	2	23	2461	8805	0.366739748274462
R-HSA-4086398	Ca2+ pathway	 49	0.649485445620747	1	10	39	2453	8789	0.935560582332811
R-HSA-4086400	PCP/CE pathway	 66	0.998215677644343	1	6	60	2457	8768	0.416749713948252
R-HSA-416476	G alpha (q) signalling events	 87	0.999473378455709	1	8	79	2455	8749	0.421539940545359
R-HSA-416482	G alpha (12/13) signalling events	 55	0.935512997604842	1	8	47	2455	8781	0.666799542317204
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	 19	0.94141524269545	1	2	17	2461	8811	0.482552300361134
R-HSA-416700	Other semaphorin interactions	 12	0.773245924790558	1	2	10	2461	8818	0.764041142238463
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	 13	0.811369397758936	1	2	11	2461	8817	0.705268746681658
R-HSA-417957	P2Y receptors	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-418038	Nucleotide-like (purinergic) receptors	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-418217	G beta:gamma signalling through PLC beta	 15	1	1	0	15	2463	8813	0
R-HSA-418346	Platelet homeostasis	 61	0.346196651389501	1	15	46	2448	8782	1.1272738164174
R-HSA-418359	Reduction of cytosolic Ca++ levels	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-418360	Platelet calcium homeostasis	 18	0.575084162208403	1	4	14	2459	8814	1.01872152298462
R-HSA-418457	cGMP effects	 12	0.255573064839343	1	4	8	2459	8820	1.52808228447693
R-HSA-418555	G alpha (s) signalling events	 75	0.786090710935707	1	14	61	2449	8767	0.855726079307078
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	 19	0.817427561137355	1	3	16	2460	8812	0.723828450541701
R-HSA-418597	G alpha (z) signalling events	 39	0.948225526008718	1	5	34	2458	8794	0.587723955568048
R-HSA-418885	DCC mediated attractive signaling	 11	0.442679157081878	1	3	8	2460	8820	1.25024914184476
R-HSA-418886	Netrin mediated repulsion signals	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-418889	Ligand-independent caspase activation via DCC	  8	1	1	0	8	2463	8820	0
R-HSA-418890	Role of second messengers in netrin-1 signaling	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-418990	Adherens junctions interactions	 23	0.996538463250731	1	1	22	2462	8806	0.199315080583947
R-HSA-419037	NCAM1 interactions	 25	0.294467224227875	1	7	18	2456	8810	1.28358911896062
R-HSA-419408	Lysosphingolipid and LPA receptors	 11	0.933344122993706	1	1	10	2462	8818	0.416749713948252
R-HSA-419812	Calcitonin-like ligand receptors	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-420029	Tight junction interactions	  9	1	1	0	9	2463	8819	0
R-HSA-420092	Glucagon-type ligand receptors	 18	0.988123330352398	1	1	17	2462	8811	0.254680380746154
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	  8	0.548719530599867	1	2	6	2461	8822	1.14606171335769
R-HSA-420597	Nectin/Necl  trans heterodimerization	  6	1	1	0	6	2463	8822	0
R-HSA-421270	Cell-cell junction organization	 32	0.999624315485667	1	1	31	2462	8797	0.143257714169712
R-HSA-421837	Clathrin derived vesicle budding	 53	0.0975656793898668	1	16	37	2447	8791	1.3839235783942
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	 11	0.442679157081878	1	3	8	2460	8820	1.25024914184476
R-HSA-422356	Regulation of insulin secretion	 64	0.980740186952625	1	8	56	2455	8772	0.573030856678847
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	 64	0.957406366929302	1	9	55	2454	8773	0.644659713763703
R-HSA-425381	Bicarbonate transporters	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	 62	0.896301670637841	1	10	52	2453	8776	0.739394653779157
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	 24	0.801106610055997	1	4	20	2459	8808	0.764041142238463
R-HSA-425410	Metal ion SLC transporters	 19	0.817427561137355	1	3	16	2460	8812	0.723828450541701
R-HSA-425561	Sodium/Calcium exchangers	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	  8	0.244235637590807	1	3	5	2460	8823	1.71909257003654
R-HSA-426496	Post-transcriptional silencing by small RNAs	  7	0.00693660267617322	0.695798657803718	5	2	2458	8826	3.27446203816484
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	 17	0.751218570046053	1	3	14	2460	8814	0.808984738840725
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	 27	0.95351290493781	1	3	24	2460	8804	0.509360761492308
R-HSA-427413	NoRC negatively regulates rRNA expression	 46	0.186673747042883	1	13	33	2450	8795	1.29554802379565
R-HSA-428157	Sphingolipid metabolism	 58	0.633260584336963	1	12	46	2451	8782	0.948464866227057
R-HSA-428540	Activation of Rac	  9	0.111410172608924	1	4	5	2459	8823	2.03744304596923
R-HSA-428543	Inactivation of Cdc42 and Rac	  6	0.122356109046401	1	3	3	2460	8825	2.29212342671539
R-HSA-428643	Organic anion transporters	  5	1	1	0	5	2463	8823	0
R-HSA-428790	Facilitative Na+-independent glucose transporters	  7	1	1	0	7	2463	8821	0
R-HSA-428890	Role of Abl in Robo-Slit signaling	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-428930	Thromboxane signalling through TP receptor	 17	0.751218570046053	1	3	14	2460	8814	0.808984738840725
R-HSA-429914	Deadenylation-dependent mRNA decay	 40	0.670160343155598	1	8	32	2455	8796	0.916849370686155
R-HSA-429947	Deadenylation of mRNA	 16	0.258933838822878	1	5	11	2458	8817	1.43257714169712
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	 14	0.968169651082891	1	1	13	2462	8815	0.327446203816484
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-430116	GP1b-IX-V activation signalling	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	 33	0.876142269754066	1	5	28	2458	8800	0.694582856580421
R-HSA-432142	Platelet sensitization by LDL	 15	0.213917686252712	1	5	10	2458	8818	1.52808228447693
R-HSA-432720	Lysosome Vesicle Biogenesis	 23	0.77186805762775	1	4	19	2459	8809	0.797260322335787
R-HSA-432722	Golgi Associated Vesicle Biogenesis	 43	0.0682505684775124	1	14	29	2449	8799	1.49254548716351
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-435354	Zinc transporters	 14	0.617640430073683	1	3	11	2460	8817	0.982338611449452
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	  6	0.389152784561032	1	2	4	2461	8824	1.52808228447693
R-HSA-437239	Recycling pathway of L1	 34	0.892219221124841	1	5	29	2458	8799	0.674153949033938
R-HSA-438064	Post NMDA receptor activation events	 32	0.940825317031644	1	4	28	2459	8800	0.573030856678847
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	 16	0.980555822903616	1	1	15	2462	8813	0.286515428339423
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	  7	1	1	0	7	2463	8821	0
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	 14	0.843657559039812	1	2	12	2461	8816	0.654892407632968
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	  5	1	1	0	5	2463	8823	0
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	 15	0.975121690577689	1	1	14	2462	8814	0.305616456895385
R-HSA-442742	CREB phosphorylation through the activation of Ras	 27	0.870941024335566	1	4	23	2459	8805	0.679147681989745
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	 36	0.919029604038895	1	5	31	2458	8797	0.636700951865385
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	 17	0.98480336243252	1	1	16	2462	8812	0.269661579613575
R-HSA-444257	RSK activation	  6	0.389152784561032	1	2	4	2461	8824	1.52808228447693
R-HSA-445095	Interaction between L1 and Ankyrins	 23	0.97427039655651	1	2	21	2461	8807	0.398630161167894
R-HSA-445144	Signal transduction by L1	 13	0.309984624601335	1	4	9	2459	8819	1.41053749336332
R-HSA-445355	Smooth Muscle Contraction	 27	0.988960097306221	1	2	25	2461	8803	0.339573840994872
R-HSA-445717	Aquaporin-mediated transport	 35	0.906461254922447	1	5	30	2458	8798	0.654892407632968
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	 19	0.402121517414399	1	5	14	2458	8814	1.20638075090284
R-HSA-446107	Type I hemidesmosome assembly	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	 56	0.943208391862415	1	8	48	2455	8780	0.654892407632968
R-HSA-446199	Synthesis of Dolichyl-phosphate	  5	1	1	0	5	2463	8823	0
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	 47	0.985625268223876	1	5	42	2458	8786	0.487685835471359
R-HSA-446353	Cell-extracellular matrix interactions	 14	0.617640430073683	1	3	11	2460	8817	0.982338611449452
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	  6	0.389152784561032	1	2	4	2461	8824	1.52808228447693
R-HSA-446652	Interleukin-1 signaling	 24	0.625675295486514	1	5	19	2458	8809	0.955051427798078
R-HSA-446728	Cell junction organization	 49	0.971179561917565	1	6	43	2457	8785	0.561336349399687
R-HSA-447038	NrCAM interactions	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-447041	CHL1 interactions	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-447043	Neurofascin interactions	  6	0.122356109046401	1	3	3	2460	8825	2.29212342671539
R-HSA-448424	Interleukin-17 signaling	  6	1	1	0	6	2463	8822	0
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	 28	0.593524717781401	1	6	22	2457	8806	0.982338611449452
R-HSA-450294	MAP kinase activation in TLR cascade	 47	0.592696615341973	1	10	37	2453	8791	0.975371670942718
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	 10	0.377417662941624	1	3	7	2460	8821	1.37527405602923
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-450341	Activation of the AP-1 family of transcription factors	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	 16	0.711460845424228	1	3	13	2460	8815	0.85954628501827
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	 37	0.974404597562454	1	4	33	2459	8795	0.495594254424949
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	 15	0.66696455478643	1	3	12	2460	8816	0.916849370686155
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	 61	0.938195838162578	1	9	52	2454	8776	0.676364289850442
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	 14	0.843657559039812	1	2	12	2461	8816	0.654892407632968
R-HSA-451306	Ionotropic activity of Kainate Receptors	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	 23	0.996538463250731	1	1	22	2462	8806	0.199315080583947
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	 22	0.739345982007313	1	4	18	2459	8810	0.833499427896505
R-HSA-453276	Regulation of mitotic cell cycle	 54	0.995693745762011	1	5	49	2458	8779	0.42446730124359
R-HSA-453279	Mitotic G1-G1/S phases	 96	0.993422652602538	1	12	84	2451	8744	0.573030856678847
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	 21	0.868010692524077	1	3	18	2460	8810	0.654892407632968
R-HSA-4570464	SUMOylation of RNA binding proteins	 31	0.528963557258349	1	7	24	2456	8804	1.03515251529082
R-HSA-4608870	Asymmetric localization of PCP proteins	 45	0.993886339880301	1	4	41	2459	8787	0.407488609193847
R-HSA-4615885	SUMOylation of DNA replication proteins	 29	0.630454001273273	1	6	23	2457	8805	0.948464866227057
R-HSA-4641257	Degradation of AXIN	 39	0.995326194352807	1	3	36	2460	8792	0.352634373340829
R-HSA-4641258	Degradation of DVL	 42	0.989422338137774	1	4	38	2459	8790	0.436594938421979
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	 27	0.22051065576388	1	8	19	2455	8809	1.35829536397949
R-HSA-4641263	Regulation of FZD by ubiquitination	 12	0.505047854496056	1	3	9	2460	8819	1.14606171335769
R-HSA-4641265	Repression of WNT target genes	 13	1	1	0	13	2463	8815	0
R-HSA-4791275	Signaling by WNT in cancer	 25	0.472525174770668	1	6	19	2457	8809	1.10021924482339
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	 13	0.133147055374859	1	5	8	2458	8820	1.76317186670414
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	 14	0.171703854694588	1	5	9	2458	8819	1.63723101908242
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	 13	0.133147055374859	1	5	8	2458	8820	1.76317186670414
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	 13	0.133147055374859	1	5	8	2458	8820	1.76317186670414
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	 18	0.575084162208403	1	4	14	2459	8814	1.01872152298462
R-HSA-500657	Presynaptic function of Kainate receptors	 15	1	1	0	15	2463	8813	0
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	 79	0.569661820473002	1	17	62	2446	8766	0.986483500105357
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	 17	0.912595190441152	1	2	15	2461	8813	0.53932315922715
R-HSA-5099900	WNT5A-dependent internalization of FZD4	 12	0.947898504648538	1	1	11	2462	8817	0.382020571119231
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	 11	1	1	0	11	2463	8817	0
R-HSA-5173105	O-linked glycosylation	 59	0.921514833075961	1	9	50	2454	8778	0.69929189289622
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	 19	0.94141524269545	1	2	17	2461	8811	0.482552300361134
R-HSA-5205647	Mitophagy	 12	0.947898504648538	1	1	11	2462	8817	0.382020571119231
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	 12	0.947898504648538	1	1	11	2462	8817	0.382020571119231
R-HSA-5210891	Uptake and function of anthrax toxins	  8	0.548719530599867	1	2	6	2461	8822	1.14606171335769
R-HSA-5213460	RIPK1-mediated regulated necrosis	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-5218859	Regulated Necrosis	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-5218900	CASP8 activity is inhibited	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-5218920	VEGFR2 mediated vascular permeability	 20	0.449915388525238	1	5	15	2458	8813	1.14606171335769
R-HSA-5223345	Miscellaneous transport and binding events	 16	0.711460845424228	1	3	13	2460	8815	0.85954628501827
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	 48	0.482721493915754	1	11	37	2452	8791	1.05055657057789
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	 35	0.217499919115322	1	10	25	2453	8803	1.30978481526594
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	 46	0.186673747042883	1	13	33	2450	8795	1.29554802379565
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	  5	1	1	0	5	2463	8823	0
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	  5	1	1	0	5	2463	8823	0
R-HSA-525793	Myogenesis	 19	0.218754425800588	1	6	13	2457	8815	1.4476569010834
R-HSA-5260271	Diseases of Immune System	 17	0.912595190441152	1	2	15	2461	8813	0.53932315922715
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	 24	0.132629884165308	1	8	16	2455	8812	1.52808228447693
R-HSA-5334118	DNA methylation	 16	0.893609705688787	1	2	14	2461	8814	0.573030856678847
R-HSA-5336415	Uptake and function of diphtheria toxin	  6	0.122356109046401	1	3	3	2460	8825	2.29212342671539
R-HSA-5339562	Uptake and actions of bacterial toxins	 25	0.663962825665475	1	5	20	2458	8808	0.916849370686155
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	 14	0.171703854694588	1	5	9	2458	8819	1.63723101908242
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	 19	0.94141524269545	1	2	17	2461	8811	0.482552300361134
R-HSA-5357786	TNFR1-induced proapoptotic signaling	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-5357905	Regulation of TNFR1 signaling	 23	0.386525205747609	1	6	17	2457	8811	1.19589048350368
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	 20	0.258739904081882	1	6	14	2457	8814	1.37527405602923
R-HSA-5358346	Hedgehog ligand biogenesis	 45	0.948084723559984	1	6	39	2457	8789	0.61123291379077
R-HSA-5358493	Synthesis of diphthamide-EEF2	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-5358508	Mismatch Repair	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	 14	0.171703854694588	1	5	9	2458	8819	1.63723101908242
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	 14	0.171703854694588	1	5	9	2458	8819	1.63723101908242
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	 14	0.171703854694588	1	5	9	2458	8819	1.63723101908242
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	 14	0.171703854694588	1	5	9	2458	8819	1.63723101908242
R-HSA-5362517	Signaling by Retinoic Acid	 28	0.991091063450363	1	2	26	2461	8802	0.327446203816484
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	 40	0.955592878511892	1	5	35	2458	8793	0.573030856678847
R-HSA-5365859	RA biosynthesis pathway	 12	0.947898504648538	1	1	11	2462	8817	0.382020571119231
R-HSA-5368286	Mitochondrial translation initiation	 61	0.938195838162578	1	9	52	2454	8776	0.676364289850442
R-HSA-5368287	Mitochondrial translation	 66	0.967055345611121	1	9	57	2454	8771	0.625124570922378
R-HSA-5387390	Hh mutants abrogate ligand secretion	 41	0.961990446190855	1	5	36	2458	8792	0.559054494320826
R-HSA-5389840	Mitochondrial translation elongation	 60	0.985986663625934	1	7	53	2456	8775	0.534828799566924
R-HSA-5419276	Mitochondrial translation termination	 61	0.987963322194932	1	7	54	2456	8774	0.526061114328122
R-HSA-5423646	Aflatoxin activation and detoxification	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	 13	0.133147055374859	1	5	8	2458	8820	1.76317186670414
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	 13	0.133147055374859	1	5	8	2458	8820	1.76317186670414
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	 13	0.133147055374859	1	5	8	2458	8820	1.76317186670414
R-HSA-549127	Organic cation transport	  6	1	1	0	6	2463	8822	0
R-HSA-549132	Organic cation/anion/zwitterion transport	  9	1	1	0	9	2463	8819	0
R-HSA-5576886	Phase 4 - resting membrane potential	 10	0.377417662941624	1	3	7	2460	8821	1.37527405602923
R-HSA-5576891	Cardiac conduction	 89	0.967606983270483	1	13	76	2450	8752	0.669609090950563
R-HSA-5576892	Phase 0 - rapid depolarisation	 29	0.967776254251178	1	3	26	2460	8802	0.474232433113528
R-HSA-5576893	Phase 2 - plateau phase	 14	0.843657559039812	1	2	12	2461	8816	0.654892407632968
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-5578749	Transcriptional regulation by small RNAs	 49	0.77166404525098	1	9	40	2454	8788	0.84200452409953
R-HSA-5578768	Physiological factors	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-5578775	Ion homeostasis	 41	0.909530391223361	1	6	35	2457	8793	0.670865393184992
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	 15	0.66696455478643	1	3	12	2460	8816	0.916849370686155
R-HSA-5602358	Diseases associated with the TLR signaling cascade	 17	0.912595190441152	1	2	15	2461	8813	0.53932315922715
R-HSA-5602498	MyD88 deficiency (TLR2/4)	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-5603029	IkBA variant leads to EDA-ID	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	 46	0.99492088284282	1	4	42	2459	8786	0.398630161167894
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	 12	0.773245924790558	1	2	10	2461	8818	0.764041142238463
R-HSA-5607764	CLEC7A (Dectin-1) signaling	 73	0.943844618159607	1	11	62	2452	8766	0.690776923119706
R-HSA-5610780	Degradation of GLI1 by the proteasome	 43	0.991176816297025	1	4	39	2459	8789	0.426441567761002
R-HSA-5610783	Degradation of GLI2 by the proteasome	 43	0.991176816297025	1	4	39	2459	8789	0.426441567761002
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	 43	0.991176816297025	1	4	39	2459	8789	0.426441567761002
R-HSA-5610787	Hedgehog 'off' state	 88	0.830552100602742	1	16	72	2447	8756	0.833499427896505
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	 51	0.894952194443296	1	8	43	2455	8785	0.7190975456362
R-HSA-5619084	ABC transporter disorders	 44	0.874202718890766	1	7	37	2456	8791	0.729311999409442
R-HSA-5619115	Disorders of transmembrane transporters	 46	0.901604291563448	1	7	39	2456	8789	0.697602782043814
R-HSA-5619507	Activation of HOX genes during differentiation	 51	0.894952194443296	1	8	43	2455	8785	0.7190975456362
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	 70	0.0024492587686821	0.602965911037487	26	44	2437	8784	1.70272025984572
R-HSA-5620916	VxPx cargo-targeting to cilium	 16	0.258933838822878	1	5	11	2458	8817	1.43257714169712
R-HSA-5620920	Cargo trafficking to the periciliary membrane	 39	0.486443500980137	1	9	30	2454	8798	1.05790312002249
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	 19	0.817427561137355	1	3	16	2460	8812	0.723828450541701
R-HSA-5620924	Intraflagellar transport	 42	0.0120722164603169	0.695798657803718	16	26	2447	8802	1.74637975368791
R-HSA-5621480	Dectin-2 family	  6	1	1	0	6	2463	8822	0
R-HSA-5621481	C-type lectin receptors (CLRs)	 92	0.977149881855094	1	13	79	2450	8749	0.647774011897827
R-HSA-5621575	CD209 (DC-SIGN) signaling	 18	0.928363907794598	1	2	16	2461	8812	0.509360761492308
R-HSA-5625740	RHO GTPases activate PKNs	 38	0.753037006301426	1	7	31	2456	8797	0.844466525631985
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	 18	0.786445451613584	1	3	15	2460	8813	0.764041142238463
R-HSA-5625900	RHO GTPases activate CIT	 12	0.947898504648538	1	1	11	2462	8817	0.382020571119231
R-HSA-5625970	RHO GTPases activate KTN1	  8	0.244235637590807	1	3	5	2460	8823	1.71909257003654
R-HSA-5626467	RHO GTPases activate IQGAPs	 20	0.844497618297972	1	3	17	2460	8811	0.687637028014616
R-HSA-5627117	RHO GTPases Activate ROCKs	 14	0.968169651082891	1	1	13	2462	8815	0.327446203816484
R-HSA-5627123	RHO GTPases activate PAKs	 19	0.817427561137355	1	3	16	2460	8812	0.723828450541701
R-HSA-5628897	TP53 Regulates Metabolic Genes	 66	0.595461336202515	1	14	52	2449	8776	0.972415999212589
R-HSA-5632681	Ligand-receptor interactions	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-5632684	Hedgehog 'on' state	 62	0.945309942081873	1	9	53	2454	8775	0.665455188401242
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	 33	0.756850559812393	1	6	27	2457	8801	0.833499427896505
R-HSA-5635838	Activation of SMO	 10	0.9147261342132	1	1	9	2462	8819	0.458424685343078
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-5637810	Constitutive Signaling by EGFRvIII	 13	0.563566823464473	1	3	10	2460	8818	1.05790312002249
R-HSA-5637812	Signaling by EGFRvIII in Cancer	 13	0.563566823464473	1	3	10	2460	8818	1.05790312002249
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	 13	0.563566823464473	1	3	10	2460	8818	1.05790312002249
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	 15	0.870841098155717	1	2	13	2461	8815	0.61123291379077
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	  5	0.0727556090697057	1	3	2	2460	8826	2.75054811205846
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	  5	0.0727556090697057	1	3	2	2460	8826	2.75054811205846
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-5654687	Downstream signaling of activated FGFR1	 17	0.0573083213860062	1	7	10	2456	8818	1.88763105729503
R-HSA-5654688	SHC-mediated cascade:FGFR1	 10	0.154853353408707	1	4	6	2459	8822	1.83369874137231
R-HSA-5654689	PI-3K cascade:FGFR1	  9	0.00486303678119148	0.602965911037487	6	3	2457	8825	3.05616456895385
R-HSA-5654693	FRS-mediated FGFR1 signaling	 11	0.0178365418436084	0.80774053777484	6	5	2457	8823	2.50049828368951
R-HSA-5654695	PI-3K cascade:FGFR2	  9	0.00486303678119148	0.602965911037487	6	3	2457	8825	3.05616456895385
R-HSA-5654696	Downstream signaling of activated FGFR2	 15	0.0284477541308568	0.924916724049397	7	8	2456	8820	2.1393151982677
R-HSA-5654699	SHC-mediated cascade:FGFR2	 10	0.154853353408707	1	4	6	2459	8822	1.83369874137231
R-HSA-5654700	FRS-mediated FGFR2 signaling	 11	0.0178365418436084	0.80774053777484	6	5	2457	8823	2.50049828368951
R-HSA-5654704	SHC-mediated cascade:FGFR3	 10	0.377417662941624	1	3	7	2460	8821	1.37527405602923
R-HSA-5654706	FRS-mediated FGFR3 signaling	 11	0.0699194510472838	1	5	6	2458	8822	2.08374856974126
R-HSA-5654708	Downstream signaling of activated FGFR3	 15	0.0872761915783393	1	6	9	2457	8819	1.83369874137231
R-HSA-5654710	PI-3K cascade:FGFR3	  9	0.0280837588409623	0.924916724049397	5	4	2458	8824	2.54680380746154
R-HSA-5654712	FRS-mediated FGFR4 signaling	 10	0.0462454014092495	1	5	5	2458	8823	2.29212342671539
R-HSA-5654716	Downstream signaling of activated FGFR4	 14	0.0637448165993463	1	6	8	2457	8820	1.9646772228989
R-HSA-5654719	SHC-mediated cascade:FGFR4	  9	0.310648370081749	1	3	6	2460	8822	1.52808228447693
R-HSA-5654720	PI-3K cascade:FGFR4	  8	0.0151833576966452	0.743592573472376	5	3	2458	8825	2.86515428339423
R-HSA-5654726	Negative regulation of FGFR1 signaling	 16	0.0119668181698249	0.695798657803718	8	8	2455	8820	2.29212342671539
R-HSA-5654727	Negative regulation of FGFR2 signaling	 15	0.0284477541308568	0.924916724049397	7	8	2456	8820	2.1393151982677
R-HSA-5654732	Negative regulation of FGFR3 signaling	 15	0.0872761915783393	1	6	9	2457	8819	1.83369874137231
R-HSA-5654733	Negative regulation of FGFR4 signaling	 14	0.0637448165993463	1	6	8	2457	8820	1.9646772228989
R-HSA-5654736	Signaling by FGFR1	 28	0.0274601377247034	0.924916724049397	11	17	2452	8811	1.80095412099066
R-HSA-5654738	Signaling by FGFR2	 41	0.0219604898188945	0.898254873882522	15	26	2448	8802	1.67716348296248
R-HSA-5654741	Signaling by FGFR3	 23	0.108130604094963	1	8	15	2455	8813	1.59452064467157
R-HSA-5654743	Signaling by FGFR4	 22	0.0863400367743431	1	8	14	2455	8814	1.66699885579301
R-HSA-5655253	Signaling by FGFR2 in disease	 22	0.0863400367743431	1	8	14	2455	8814	1.66699885579301
R-HSA-5655291	Signaling by FGFR4 in disease	  9	0.310648370081749	1	3	6	2460	8822	1.52808228447693
R-HSA-5655302	Signaling by FGFR1 in disease	 27	0.0206437155648454	0.898254873882522	11	16	2452	8812	1.8676561254718
R-HSA-5655332	Signaling by FGFR3 in disease	 13	0.133147055374859	1	5	8	2458	8820	1.76317186670414
R-HSA-5655862	Translesion synthesis by POLK	 13	0.133147055374859	1	5	8	2458	8820	1.76317186670414
R-HSA-5656121	Translesion synthesis by POLI	 13	0.133147055374859	1	5	8	2458	8820	1.76317186670414
R-HSA-5656169	Termination of translesion DNA synthesis	 19	0.402121517414399	1	5	14	2458	8814	1.20638075090284
R-HSA-5658442	Regulation of RAS by GAPs	 51	0.894952194443296	1	8	43	2455	8785	0.7190975456362
R-HSA-5660526	Response to metal ions	  7	1	1	0	7	2463	8821	0
R-HSA-5661231	Metallothioneins bind metals	  7	1	1	0	7	2463	8821	0
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	 31	0.837835611572131	1	5	26	2458	8802	0.739394653779157
R-HSA-5663220	RHO GTPases Activate Formins	 74	0.94993514706612	1	11	63	2452	8765	0.681442099834304
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	 60	0.995022012583366	1	6	54	2457	8774	0.458424685343078
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	  8	1	1	0	8	2463	8820	0
R-HSA-5668914	Diseases of metabolism	 20	0.258739904081882	1	6	14	2457	8814	1.37527405602923
R-HSA-5669034	TNFs bind their physiological receptors	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-5673000	RAF activation	 22	0.186322896357431	1	7	15	2456	8813	1.45862399881888
R-HSA-5674135	MAP2K and MAPK activation	 26	0.944338251537561	1	3	23	2460	8805	0.528951560011243
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	 22	0.739345982007313	1	4	18	2459	8810	0.833499427896505
R-HSA-5674499	Negative feedback regulation of MAPK pathway	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-5675221	Negative regulation of MAPK pathway	 33	0.433972919218335	1	8	25	2455	8803	1.11133257052867
R-HSA-5675482	Regulation of necroptotic cell death	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	 44	0.992650555333501	1	4	40	2459	8788	0.416749713948252
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	 11	0.728546246408141	1	2	9	2461	8819	0.833499427896505
R-HSA-5676934	Protein repair	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-5678895	Defective CFTR causes cystic fibrosis	 42	0.920992330344259	1	6	36	2457	8792	0.654892407632968
R-HSA-5682910	LGI-ADAM interactions	 13	0.959275930222671	1	1	12	2462	8816	0.352634373340829
R-HSA-5683826	Surfactant metabolism	 12	0.947898504648538	1	1	11	2462	8817	0.382020571119231
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	 24	0.429791266640398	1	6	18	2457	8810	1.14606171335769
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-5685942	HDR through Homologous Recombination (HRR)	 32	0.250119643399632	1	9	23	2454	8805	1.28931942752741
R-HSA-5686938	Regulation of TLR by endogenous ligand	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-5687128	MAPK6/MAPK4 signaling	 65	0.867933832247114	1	11	54	2452	8774	0.775795621349823
R-HSA-5689603	UCH proteinases	 64	0.957406366929302	1	9	55	2454	8773	0.644659713763703
R-HSA-5689896	Ovarian tumor domain proteases	 22	0.968316004721824	1	2	20	2461	8808	0.416749713948252
R-HSA-5689901	Metalloprotease DUBs	 12	0.505047854496056	1	3	9	2460	8819	1.14606171335769
R-HSA-5690714	CD22 mediated BCR regulation	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-5693532	DNA Double-Strand Break Repair	 81	0.71518173981736	1	16	65	2447	8763	0.905530242652993
R-HSA-5693537	Resolution of D-Loop Structures	 14	0.171703854694588	1	5	9	2458	8819	1.63723101908242
R-HSA-5693538	Homology Directed Repair	 62	0.727711564075295	1	12	50	2451	8778	0.887273584534989
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	 12	0.255573064839343	1	4	8	2459	8820	1.52808228447693
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	 35	0.806767018339206	1	6	29	2457	8799	0.785870889159561
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	 60	0.682543867010833	1	12	48	2451	8780	0.916849370686155
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	 14	0.171703854694588	1	5	9	2458	8819	1.63723101908242
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	 33	0.756850559812393	1	6	27	2457	8801	0.833499427896505
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	 24	0.429791266640398	1	6	18	2457	8810	1.14606171335769
R-HSA-5693606	DNA Double Strand Break Response	 35	0.806767018339206	1	6	29	2457	8799	0.785870889159561
R-HSA-5693607	Processing of DNA double-strand break ends	 44	0.874202718890766	1	7	37	2456	8791	0.729311999409442
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	 23	0.386525205747609	1	6	17	2457	8811	1.19589048350368
R-HSA-5694530	Cargo concentration in the ER	 24	0.429791266640398	1	6	18	2457	8810	1.14606171335769
R-HSA-5696394	DNA Damage Recognition in GG-NER	 24	0.979135854508336	1	2	22	2461	8806	0.382020571119231
R-HSA-5696395	Formation of Incision Complex in GG-NER	 31	0.118880687967972	1	10	21	2453	8807	1.47878930755831
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	 13	0.563566823464473	1	3	10	2460	8818	1.05790312002249
R-HSA-5696398	Nucleotide Excision Repair	 73	0.424910237445608	1	17	56	2446	8772	1.06756433573045
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	 57	0.479485918781927	1	13	44	2450	8784	1.04552998411579
R-HSA-5696400	Dual Incision in GG-NER	 28	0.0655465144564654	1	10	18	2453	8810	1.63723101908242
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	 24	0.801106610055997	1	4	20	2459	8808	0.764041142238463
R-HSA-611105	Respiratory electron transport	 63	0.839536920432536	1	11	52	2452	8776	0.800424053773627
R-HSA-622312	Inflammasomes	 11	0.933344122993706	1	1	10	2462	8818	0.416749713948252
R-HSA-674695	RNA Polymerase II Pre-transcription Events	 52	0.0458916256877357	1	17	35	2446	8793	1.49869608669852
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	 35	0.217499919115322	1	10	25	2453	8803	1.30978481526594
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	 51	0.206566923360747	1	14	37	2449	8791	1.25842070486335
R-HSA-6782135	Dual incision in TC-NER	 44	0.0807902485883511	1	14	30	2449	8798	1.45862399881888
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	 40	0.144121621312437	1	12	28	2451	8800	1.37527405602923
R-HSA-6782315	tRNA modification in the nucleus and cytosol	 30	0.0456592411954089	1	11	19	2452	8809	1.68089051292462
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-6783310	Fanconi Anemia Pathway	 21	0.703419172941338	1	4	17	2459	8811	0.873189876843957
R-HSA-6783589	Interleukin-6 family signaling	 22	0.186322896357431	1	7	15	2456	8813	1.45862399881888
R-HSA-6783783	Interleukin-10 signaling	 24	0.997295098413444	1	1	23	2462	8805	0.191010285559616
R-HSA-6784531	tRNA processing in the nucleus	 44	0.644857315416143	1	9	35	2454	8793	0.937686856383568
R-HSA-6785631	ERBB2 Regulates Cell Motility	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-6785807	Interleukin-4 and 13 signaling	 68	0.974685043516736	1	9	59	2454	8769	0.606738554130544
R-HSA-6787450	tRNA modification in the mitochondrion	  6	0.122356109046401	1	3	3	2460	8825	2.29212342671539
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	 15	0.420343931222697	1	4	11	2459	8817	1.22246582758154
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	 26	0.850434814350682	1	4	22	2459	8806	0.705268746681658
R-HSA-6790901	rRNA modification in the nucleus and cytosol	 31	0.528963557258349	1	7	24	2456	8804	1.03515251529082
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	 73	0.537496521327437	1	16	57	2447	8771	1.00476643362866
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	 31	0.528963557258349	1	7	24	2456	8804	1.03515251529082
R-HSA-6794361	Interactions of neurexins and neuroligins at synapses	 48	0.923747487734536	1	7	41	2456	8787	0.668535999458655
R-HSA-6794362	Protein-protein interactions at synapses	 58	0.956204295208088	1	8	50	2455	8778	0.632309910818038
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	 34	0.0501397734814464	1	12	22	2451	8806	1.61796947768145
R-HSA-6798163	Choline catabolism	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-6799198	Complex I biogenesis	 35	0.906461254922447	1	5	30	2458	8798	0.654892407632968
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	 27	0.870941024335566	1	4	23	2459	8805	0.679147681989745
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	 24	0.979135854508336	1	2	22	2461	8806	0.382020571119231
R-HSA-6802949	Signaling by RAS mutants	 36	0.697914658032877	1	7	29	2456	8799	0.89138133261154
R-HSA-6802952	Signaling by BRAF and RAF fusions	 44	0.874202718890766	1	7	37	2456	8791	0.729311999409442
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	 27	0.870941024335566	1	4	23	2459	8805	0.679147681989745
R-HSA-6802957	Oncogenic MAPK signaling	 55	0.679326523469202	1	11	44	2452	8784	0.916849370686155
R-HSA-6803157	Antimicrobial peptides	 23	1	1	0	23	2463	8805	0
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	 15	0.66696455478643	1	3	12	2460	8816	0.916849370686155
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	  8	0.0743762109342742	1	4	4	2459	8824	2.29212342671539
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-6803529	FGFR2 alternative splicing	 18	0.0766996906860068	1	7	11	2456	8817	1.78276266522308
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	 14	0.365296932564035	1	4	10	2459	8818	1.30978481526594
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	 56	0.580321223379766	1	12	44	2451	8784	0.982338611449452
R-HSA-6804757	Regulation of TP53 Degradation	 24	0.256727023069242	1	7	17	2456	8811	1.33707199891731
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	 25	0.933503239554459	1	3	22	2460	8806	0.550109622411693
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-6804760	Regulation of TP53 Activity through Methylation	 11	0.442679157081878	1	3	8	2460	8820	1.25024914184476
R-HSA-6805567	Keratinization	 22	1	1	0	22	2463	8806	0
R-HSA-6806003	Regulation of TP53 Expression and Degradation	 24	0.256727023069242	1	7	17	2456	8811	1.33707199891731
R-HSA-6806667	Metabolism of fat-soluble vitamins	 26	0.986334379353005	1	2	24	2461	8804	0.352634373340829
R-HSA-6806834	Signaling by MET	 55	0.423077641181111	1	13	42	2450	8786	1.08354925626546
R-HSA-6807004	Negative regulation of MET activity	 14	0.0637448165993463	1	6	8	2457	8820	1.9646772228989
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	 46	0.186673747042883	1	13	33	2450	8795	1.29554802379565
R-HSA-6807878	COPI-mediated anterograde transport	 66	0.707930522840256	1	13	53	2450	8775	0.902957713554547
R-HSA-6809371	Formation of the cornified envelope	 21	1	1	0	21	2463	8807	0
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	 60	0.930286331774581	1	9	51	2454	8777	0.687637028014616
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	 31	0.528963557258349	1	7	24	2456	8804	1.03515251529082
R-HSA-6811438	Intra-Golgi traffic	 32	0.00450169863910773	0.602965911037487	14	18	2449	8810	2.00560799837596
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	 34	0.0218731618195241	0.898254873882522	13	21	2450	8807	1.75280026748824
R-HSA-6811555	PI5P Regulates TP53 Acetylation	  7	1	1	0	7	2463	8821	0
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	 51	0.206566923360747	1	14	37	2449	8791	1.25842070486335
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	 31	0.930480623433657	1	4	27	2459	8801	0.591515723023326
R-HSA-6814848	Glycerophospholipid catabolism	  5	1	1	0	5	2463	8823	0
R-HSA-68616	Assembly of the ORC complex at the origin of replication	  5	1	1	0	5	2463	8823	0
R-HSA-68689	CDC6 association with the ORC:origin complex	  6	1	1	0	6	2463	8822	0
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	 41	0.996872094890805	1	3	38	2460	8790	0.335432696592496
R-HSA-68867	Assembly of the pre-replicative complex	 46	0.998873584162163	1	3	43	2460	8785	0.29897262087592
R-HSA-68874	M/G1 Transition	 55	0.999829665868208	1	3	52	2460	8776	0.250049828368951
R-HSA-68875	Mitotic Prophase	 72	0.297083087663002	1	18	54	2445	8774	1.14606171335769
R-HSA-68877	Mitotic Prometaphase	 68	0.83685841816256	1	12	56	2451	8772	0.808984738840725
R-HSA-68884	Mitotic Telophase/Cytokinesis	 10	0.154853353408707	1	4	6	2459	8822	1.83369874137231
R-HSA-68949	Orc1 removal from chromatin	 50	0.997609181133935	1	4	46	2459	8782	0.366739748274462
R-HSA-68962	Activation of the pre-replicative complex	 20	1	1	0	20	2463	8808	0
R-HSA-69002	DNA Replication Pre-Initiation	 55	0.999829665868208	1	3	52	2460	8776	0.250049828368951
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	 35	0.989709087019115	1	3	32	2460	8796	0.392935444579781
R-HSA-69052	Switching of origins to a post-replicative state	 50	0.997609181133935	1	4	46	2459	8782	0.366739748274462
R-HSA-69091	Polymerase switching	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-69109	Leading Strand Synthesis	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-69166	Removal of the Flap Intermediate	  9	1	1	0	9	2463	8819	0
R-HSA-69183	Processive synthesis on the lagging strand	  9	1	1	0	9	2463	8819	0
R-HSA-69186	Lagging Strand Synthesis	 14	0.843657559039812	1	2	12	2461	8816	0.654892407632968
R-HSA-69190	DNA strand elongation	 20	0.952183867628503	1	2	18	2461	8810	0.458424685343078
R-HSA-69202	Cyclin E associated events during G1/S transition 	 51	0.978761718009559	1	6	45	2457	8783	0.53932315922715
R-HSA-69205	G1/S-Specific Transcription	  8	0.548719530599867	1	2	6	2461	8822	1.14606171335769
R-HSA-69206	G1/S Transition	 82	0.991502861174246	1	10	72	2453	8756	0.559054494320826
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	 35	0.989709087019115	1	3	32	2460	8796	0.392935444579781
R-HSA-69231	Cyclin D associated events in G1	 24	0.132629884165308	1	8	16	2455	8812	1.52808228447693
R-HSA-69236	G1 Phase	 24	0.132629884165308	1	8	16	2455	8812	1.52808228447693
R-HSA-69239	Synthesis of DNA	 67	0.998501987156203	1	6	61	2457	8767	0.41052956896395
R-HSA-69242	S Phase	 87	0.990183529270698	1	11	76	2452	8752	0.579617418249868
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	 12	0.505047854496056	1	3	9	2460	8819	1.14606171335769
R-HSA-69298	Association of licensing factors with the pre-replicative complex	  6	1	1	0	6	2463	8822	0
R-HSA-69300	Removal of licensing factors from origins	 51	0.998025161447459	1	4	47	2459	8781	0.3595487728181
R-HSA-69304	Regulation of DNA replication	 51	0.998025161447459	1	4	47	2459	8781	0.3595487728181
R-HSA-69306	DNA Replication	 70	0.999118967114964	1	6	64	2457	8764	0.392935444579781
R-HSA-69416	Dimerization of procaspase-8	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-69473	G2/M DNA damage checkpoint	 47	0.961169951393572	1	6	41	2457	8787	0.585223002565631
R-HSA-69481	G2/M Checkpoints	 93	0.999396944737233	1	9	84	2454	8744	0.443636792267494
R-HSA-69541	Stabilization of p53	 38	0.978479754460976	1	4	34	2459	8794	0.482552300361134
R-HSA-69563	p53-Dependent G1 DNA Damage Response	 45	0.979983763728802	1	5	40	2458	8788	0.509360761492308
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	 45	0.979983763728802	1	5	40	2458	8788	0.509360761492308
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	 35	0.96399250244369	1	4	31	2459	8797	0.523913926106374
R-HSA-69610	p53-Independent DNA Damage Response	 35	0.96399250244369	1	4	31	2459	8797	0.523913926106374
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	 35	0.96399250244369	1	4	31	2459	8797	0.523913926106374
R-HSA-69615	G1/S DNA Damage Checkpoints	 45	0.979983763728802	1	5	40	2458	8788	0.509360761492308
R-HSA-69618	Mitotic Spindle Checkpoint	 13	0.959275930222671	1	1	12	2462	8816	0.352634373340829
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	 49	0.971179561917565	1	6	43	2457	8785	0.561336349399687
R-HSA-70153	Glucose transport	 30	0.665341631849666	1	6	24	2457	8804	0.916849370686155
R-HSA-70171	Glycolysis	 20	0.992746348136518	1	1	19	2462	8809	0.229212342671539
R-HSA-70221	Glycogen breakdown (glycogenolysis)	 14	0.617640430073683	1	3	11	2460	8817	0.982338611449452
R-HSA-70263	Gluconeogenesis	 20	0.952183867628503	1	2	18	2461	8810	0.458424685343078
R-HSA-70268	Pyruvate metabolism	 23	0.905794890457623	1	3	20	2460	8808	0.59794524175184
R-HSA-70326	Glucose metabolism	 56	0.889340632059403	1	9	47	2454	8781	0.736753958587089
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	 24	0.429791266640398	1	6	18	2457	8810	1.14606171335769
R-HSA-70635	Urea cycle	  5	1	1	0	5	2463	8823	0
R-HSA-70895	Branched-chain amino acid catabolism	 18	0.000354510861802673	0.449519772765789	11	7	2452	8821	2.8014841882077
R-HSA-71064	Lysine catabolism	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-71182	Phenylalanine and tyrosine catabolism	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-71240	Tryptophan catabolism	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-71288	Creatine metabolism	  6	1	1	0	6	2463	8822	0
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	  8	0.548719530599867	1	2	6	2461	8822	1.14606171335769
R-HSA-71384	Ethanol oxidation	  5	1	1	0	5	2463	8823	0
R-HSA-71403	Citric acid cycle (TCA cycle)	 16	1	1	0	16	2463	8812	0
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	 40	0.984864547465129	1	4	36	2459	8792	0.458424685343078
R-HSA-72086	mRNA Capping	 17	0.146286057441442	1	6	11	2457	8817	1.61796947768145
R-HSA-72165	mRNA Splicing - Minor Pathway	 32	0.140780878730798	1	10	22	2453	8806	1.43257714169712
R-HSA-72187	mRNA 3'-end processing	 44	0.00120376484107701	0.602965911037487	19	25	2444	8803	1.9795611412542
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	 59	0.0106084772877996	0.695798657803718	21	38	2442	8790	1.63168108342451
R-HSA-72306	tRNA processing	 79	0.123128415607649	1	22	57	2441	8771	1.2766257060187
R-HSA-72312	rRNA processing	 84	0.577108930183026	1	18	66	2445	8762	0.982338611449452
R-HSA-72613	Eukaryotic Translation Initiation	 39	0.486443500980137	1	9	30	2454	8798	1.05790312002249
R-HSA-72649	Translation initiation complex formation	 20	0.844497618297972	1	3	17	2460	8811	0.687637028014616
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	 21	0.868010692524077	1	3	18	2460	8810	0.654892407632968
R-HSA-72689	Formation of a pool of free 40S subunits	 26	0.333299852000256	1	7	19	2456	8809	1.2342203066929
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	 17	0.751218570046053	1	3	14	2460	8814	0.808984738840725
R-HSA-72702	Ribosomal scanning and start codon recognition	 21	0.703419172941338	1	4	17	2459	8811	0.873189876843957
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	 33	0.433972919218335	1	8	25	2455	8803	1.11133257052867
R-HSA-72731	Recycling of eIF2:GDP	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-72737	Cap-dependent Translation Initiation	 39	0.486443500980137	1	9	30	2454	8798	1.05790312002249
R-HSA-72764	Eukaryotic Translation Termination	 21	0.154510168308267	1	7	14	2456	8814	1.52808228447693
R-HSA-72766	Translation	 64	0.0505166630427352	1	20	44	2443	8784	1.43257714169712
R-HSA-727802	Transport of nucleotide sugars	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-73728	RNA Polymerase I Promoter Opening	 14	0.843657559039812	1	2	12	2461	8816	0.654892407632968
R-HSA-73762	RNA Polymerase I Transcription Initiation	 33	0.282184918609767	1	9	24	2454	8804	1.25024914184476
R-HSA-73772	RNA Polymerase I Promoter Escape	 19	0.0994496733593998	1	7	12	2456	8816	1.68893305126397
R-HSA-73776	RNA Polymerase II Promoter Escape	 31	0.360411781971192	1	8	23	2455	8805	1.18303144604665
R-HSA-73777	RNA Polymerase I Chain Elongation	 33	0.282184918609767	1	9	24	2454	8804	1.25024914184476
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	 31	0.360411781971192	1	8	23	2455	8805	1.18303144604665
R-HSA-73780	RNA Polymerase III Chain Elongation	 15	0.870841098155717	1	2	13	2461	8815	0.61123291379077
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	 10	0.9147261342132	1	1	9	2462	8819	0.458424685343078
R-HSA-73847	Purine metabolism	 23	0.77186805762775	1	4	19	2459	8809	0.797260322335787
R-HSA-73848	Pyrimidine metabolism	 10	0.377417662941624	1	3	7	2460	8821	1.37527405602923
R-HSA-73854	RNA Polymerase I Promoter Clearance	 47	0.452034544438049	1	11	36	2452	8792	1.07290883803699
R-HSA-73856	RNA Polymerase II Transcription Termination	 49	0.00523077683076685	0.602965911037487	19	30	2444	8798	1.77756510643234
R-HSA-73857	RNA Polymerase II Transcription	100	0.00164975915502073	0.602965911037487	35	65	2428	8763	1.60448639870077
R-HSA-73863	RNA Polymerase I Transcription Termination	 20	0.125454976477568	1	7	13	2456	8815	1.60448639870077
R-HSA-73864	RNA Polymerase I Transcription	 49	0.513030202251722	1	11	38	2452	8790	1.02911664056609
R-HSA-73884	Base Excision Repair	 24	0.801106610055997	1	4	20	2459	8808	0.764041142238463
R-HSA-73886	Chromosome Maintenance	 46	0.901604291563448	1	7	39	2456	8789	0.697602782043814
R-HSA-73887	Death Receptor Signalling	 36	0.142884144112005	1	11	25	2452	8803	1.40074209410385
R-HSA-73893	DNA Damage Bypass	 31	0.219368115836522	1	9	22	2454	8806	1.33091037680248
R-HSA-73923	Lipid digestion, mobilization, and transport	 60	0.966470309877881	1	8	52	2455	8776	0.61123291379077
R-HSA-73928	Depyrimidination	  6	0.389152784561032	1	2	4	2461	8824	1.52808228447693
R-HSA-73929	Base-Excision Repair, AP Site Formation	  6	0.389152784561032	1	2	4	2461	8824	1.52808228447693
R-HSA-73933	Resolution of Abasic Sites (AP sites)	 24	0.801106610055997	1	4	20	2459	8808	0.764041142238463
R-HSA-73942	DNA Damage Reversal	  6	1	1	0	6	2463	8822	0
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	  6	1	1	0	6	2463	8822	0
R-HSA-73980	RNA Polymerase III Transcription Termination	 20	0.844497618297972	1	3	17	2460	8811	0.687637028014616
R-HSA-74158	RNA Polymerase III Transcription	 35	0.806767018339206	1	6	29	2457	8799	0.785870889159561
R-HSA-74182	Ketone body metabolism	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-74217	Purine salvage	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-74749	Signal attenuation	  7	0.180538352594607	1	3	4	2460	8824	1.9646772228989
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	 35	0.806767018339206	1	6	29	2457	8799	0.785870889159561
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	  7	1	1	0	7	2463	8821	0
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	 23	0.58486612281024	1	5	18	2458	8810	0.996575402919734
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	 35	0.028027684799303	0.924916724049397	13	22	2450	8806	1.70272025984572
R-HSA-75109	Triglyceride Biosynthesis	 49	0.0963613487077588	1	15	34	2448	8794	1.40334087349922
R-HSA-75153	Apoptotic execution  phase	 37	0.043952871845349	1	13	24	2450	8804	1.61068132688108
R-HSA-75158	TRAIL  signaling	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-75205	Dissolution of Fibrin Clot	  8	1	1	0	8	2463	8820	0
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	 35	0.989709087019115	1	3	32	2460	8796	0.392935444579781
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	 20	0.00503069533471213	0.602965911037487	10	10	2453	8818	2.29212342671539
R-HSA-75892	Platelet Adhesion to exposed collagen	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-75893	TNF signaling	 30	0.0990097083008909	1	10	20	2453	8808	1.52808228447693
R-HSA-75953	RNA Polymerase II Transcription Initiation	 31	0.360411781971192	1	8	23	2455	8805	1.18303144604665
R-HSA-75955	RNA Polymerase II Transcription Elongation	 35	0.0114578152383597	0.695798657803718	14	21	2449	8807	1.83369874137231
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	 88	0.830552100602742	1	16	72	2447	8756	0.833499427896505
R-HSA-76009	Platelet Aggregation (Plug Formation)	 21	0.868010692524077	1	3	18	2460	8810	0.654892407632968
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	 31	0.360411781971192	1	8	23	2455	8805	1.18303144604665
R-HSA-76046	RNA Polymerase III Transcription Initiation	 30	0.815293153213977	1	5	25	2458	8803	0.764041142238463
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	 23	0.77186805762775	1	4	19	2459	8809	0.797260322335787
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	 22	0.739345982007313	1	4	18	2459	8810	0.833499427896505
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	 24	0.801106610055997	1	4	20	2459	8808	0.764041142238463
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	 15	0.213917686252712	1	5	10	2458	8818	1.52808228447693
R-HSA-77111	Synthesis of Ketone Bodies	  6	0.389152784561032	1	2	4	2461	8824	1.52808228447693
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	 16	0.711460845424228	1	3	13	2460	8815	0.85954628501827
R-HSA-77387	Insulin receptor recycling	 16	0.893609705688787	1	2	14	2461	8814	0.573030856678847
R-HSA-774815	Nucleosome assembly	 24	0.801106610055997	1	4	20	2459	8808	0.764041142238463
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-77595	Processing of Intronless Pre-mRNAs	 18	0.353867019621291	1	5	13	2458	8815	1.27340190373077
R-HSA-804914	Transport of fatty acids	  5	1	1	0	5	2463	8823	0
R-HSA-844456	The NLRP3 inflammasome	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-877300	Interferon gamma signaling	 51	0.701582767760329	1	10	41	2453	8787	0.89887193204525
R-HSA-877312	Regulation of IFNG signaling	 10	0.00992211627267498	0.695798657803718	6	4	2457	8824	2.75054811205846
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-879518	Transport of organic anions	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-8848021	Signaling by PTK6	 47	0.592696615341973	1	10	37	2453	8791	0.975371670942718
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	 22	0.54174853214445	1	5	17	2458	8811	1.04187428487063
R-HSA-8849473	PTK6 Expression	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-8849932	SALM protein interactions at the synapses	 16	0.980555822903616	1	1	15	2462	8813	0.286515428339423
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-8851680	Butyrophilin (BTN) family interactions	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-8851708	Signaling by FGFR2 IIIa TM	 12	0.0990149060241598	1	5	7	2458	8821	1.91010285559616
R-HSA-8851805	MET activates RAS signaling	 10	0.9147261342132	1	1	9	2462	8819	0.458424685343078
R-HSA-8851907	MET activates PI3K/AKT signaling	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-8852135	Protein ubiquitination	 35	0.667519130214642	1	7	28	2456	8800	0.916849370686155
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	 47	0.999084129138257	1	3	44	2460	8784	0.292611501282815
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	  9	0.310648370081749	1	3	6	2460	8822	1.52808228447693
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	 13	0.133147055374859	1	5	8	2458	8820	1.76317186670414
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	 39	0.981937380569806	1	4	35	2459	8793	0.470179164454438
R-HSA-8854214	TBC/RABGAPs	 30	0.994215917012967	1	2	28	2461	8800	0.305616456895385
R-HSA-8854518	AURKA Activation by TPX2	 50	0.0152471663330298	0.743592573472376	18	32	2445	8796	1.65032886723508
R-HSA-8855121	VLDL interactions	 17	0.98480336243252	1	1	16	2462	8812	0.269661579613575
R-HSA-8856688	Golgi-to-ER retrograde transport	 83	0.752310203209726	1	16	67	2447	8761	0.883710236805933
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	 72	0.209086271746441	1	19	53	2444	8775	1.20973180854423
R-HSA-8857538	PTK6 promotes HIF1A stabilization	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	 16	0.711460845424228	1	3	13	2460	8815	0.85954628501827
R-HSA-8863678	Neurodegenerative Diseases	 16	0.711460845424228	1	3	13	2460	8815	0.85954628501827
R-HSA-8863795	Downregulation of ERBB2 signaling	 21	0.868010692524077	1	3	18	2460	8810	0.654892407632968
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	 27	0.870941024335566	1	4	23	2459	8805	0.679147681989745
R-HSA-8865999	MET activates PTPN11	  5	0.300220559389489	1	2	3	2461	8825	1.83369874137231
R-HSA-8866376	Reelin signalling pathway	  5	0.707892814989018	1	1	4	2462	8824	0.916849370686155
R-HSA-8866427	VLDLR internalisation and degradation	 10	1	1	0	10	2463	8818	0
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	 19	0.402121517414399	1	5	14	2458	8814	1.20638075090284
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	 21	0.868010692524077	1	3	18	2460	8810	0.654892407632968
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-8868766	rRNA processing in the mitochondrion	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-8868773	rRNA processing in the nucleus and cytosol	 78	0.546246662543336	1	17	61	2446	8767	0.999130724465682
R-HSA-8873719	RAB geranylgeranylation	 46	0.983023638773844	1	5	41	2458	8787	0.498287701459867
R-HSA-8874081	MET activates PTK2 signaling	 21	0.868010692524077	1	3	18	2460	8810	0.654892407632968
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	  9	0.111410172608924	1	4	5	2459	8823	2.03744304596923
R-HSA-8875513	MET interacts with TNS proteins	  5	1	1	0	5	2463	8823	0
R-HSA-8875555	MET activates RAP1 and RAC1	  9	0.616739862176472	1	2	7	2461	8821	1.01872152298462
R-HSA-8875656	MET receptor recycling	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-8875878	MET promotes cell motility	 30	0.815293153213977	1	5	25	2458	8803	0.764041142238463
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	 69	0.666837001287683	1	14	55	2449	8773	0.930137042725085
R-HSA-8876384	Listeria monocytogenes entry into host cells	 12	0.255573064839343	1	4	8	2459	8820	1.52808228447693
R-HSA-8876725	Protein methylation	 11	0.203387011900948	1	4	7	2459	8821	1.66699885579301
R-HSA-888590	GABA synthesis, release, reuptake and degradation	 18	0.988123330352398	1	1	17	2462	8811	0.254680380746154
R-HSA-8948216	Collagen chain trimerization	 23	0.58486612281024	1	5	18	2458	8810	0.996575402919734
R-HSA-901032	ER Quality Control Compartment (ERQC)	 13	0.133147055374859	1	5	8	2458	8820	1.76317186670414
R-HSA-901042	Calnexin/calreticulin cycle	 18	0.18107924081916	1	6	12	2457	8816	1.52808228447693
R-HSA-909733	Interferon alpha/beta signaling	 45	0.888610501437667	1	7	38	2456	8790	0.713105066089232
R-HSA-912446	Meiotic recombination	 24	0.625675295486514	1	5	19	2458	8809	0.955051427798078
R-HSA-912631	Regulation of signaling by CBL	 12	0.773245924790558	1	2	10	2461	8818	0.764041142238463
R-HSA-912694	Regulation of IFNA signaling	  9	0.111410172608924	1	4	5	2459	8823	2.03744304596923
R-HSA-913709	O-linked glycosylation of mucins	 32	0.728581965523776	1	6	26	2457	8802	0.85954628501827
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	 15	0.420343931222697	1	4	11	2459	8817	1.22246582758154
R-HSA-917937	Iron uptake and transport	 29	0.904761991669314	1	4	25	2459	8803	0.632309910818038
R-HSA-917977	Transferrin endocytosis and recycling	 20	0.664030570560528	1	4	16	2459	8812	0.916849370686155
R-HSA-918233	TRAF3-dependent IRF activation pathway	 10	0.676570411985184	1	2	8	2461	8820	0.916849370686155
R-HSA-927802	Nonsense-Mediated Decay (NMD)	 39	0.0652896457214298	1	13	26	2450	8802	1.52808228447693
R-HSA-933541	TRAF6 mediated IRF7 activation	 15	0.66696455478643	1	3	12	2460	8816	0.916849370686155
R-HSA-933542	TRAF6 mediated NF-kB activation	 18	0.786445451613584	1	3	15	2460	8813	0.764041142238463
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	 27	0.732524106937597	1	5	22	2458	8806	0.848934602487181
R-HSA-936837	Ion transport by P-type ATPases	 40	0.670160343155598	1	8	32	2455	8796	0.916849370686155
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	 10	0.154853353408707	1	4	6	2459	8822	1.83369874137231
R-HSA-937039	IRAK1 recruits IKK complex	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-937041	IKK complex recruitment mediated by RIP1	 13	0.309984624601335	1	4	9	2459	8819	1.41053749336332
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling 	 73	0.319605777468988	1	18	55	2445	8773	1.13036223783225
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	  7	0.180538352594607	1	3	4	2460	8824	1.9646772228989
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	  5	1	1	0	5	2463	8823	0
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	 64	0.662671547068529	1	13	51	2450	8777	0.931175142103126
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	  6	0.771640821074615	1	1	5	2462	8823	0.764041142238463
R-HSA-975155	MyD88 dependent cascade initiated on endosome	 66	0.707930522840256	1	13	53	2450	8775	0.902957713554547
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	  7	0.180538352594607	1	3	4	2460	8824	1.9646772228989
R-HSA-975298	Ligand-gated ion channel transport	 10	0.9147261342132	1	1	9	2462	8819	0.458424685343078
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	 17	0.912595190441152	1	2	15	2461	8813	0.53932315922715
R-HSA-975577	N-Glycan antennae elongation	  9	1	1	0	9	2463	8819	0
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	  7	0.472598557347602	1	2	5	2461	8823	1.30978481526594
R-HSA-975634	Retinoid metabolism and transport	 23	0.97427039655651	1	2	21	2461	8807	0.398630161167894
R-HSA-975871	MyD88 cascade initiated on plasma membrane	 61	0.705662574983708	1	12	49	2451	8779	0.901819053133923
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	 22	0.186322896357431	1	7	15	2456	8813	1.45862399881888
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	 39	0.0652896457214298	1	13	26	2450	8802	1.52808228447693
R-HSA-977068	Termination of O-glycan biosynthesis	  8	0.860447150899962	1	1	7	2462	8821	0.573030856678847
R-HSA-977225	Amyloid fiber formation	 32	0.940825317031644	1	4	28	2459	8800	0.573030856678847
R-HSA-977347	Serine biosynthesis	  7	0.82148119836245	1	1	6	2462	8822	0.654892407632968
R-HSA-977441	GABA A receptor activation	  9	0.890910561990399	1	1	8	2462	8820	0.509360761492308
R-HSA-977443	GABA receptor activation	 40	0.996174435992348	1	3	37	2460	8791	0.343818514007308
R-HSA-977444	GABA B receptor activation	 31	0.995345930253555	1	2	29	2461	8799	0.295757861511663
R-HSA-977606	Regulation of Complement cascade	 11	0.442679157081878	1	3	8	2460	8820	1.25024914184476
R-HSA-982772	Growth hormone receptor signaling	 15	0.213917686252712	1	5	10	2458	8818	1.52808228447693
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	 18	0.353867019621291	1	5	13	2458	8815	1.27340190373077
R-HSA-983189	Kinesins	 31	0.977830725024441	1	3	28	2460	8800	0.443636792267494
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	 87	0.642064575702687	1	18	69	2445	8759	0.948464866227057
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	 29	0.288328331167283	1	8	21	2455	8807	1.26461982163608
R-HSA-991365	Activation of GABAB receptors	 31	0.995345930253555	1	2	29	2461	8799	0.295757861511663
R-HSA-997269	Inhibition of adenylate cyclase pathway	 13	0.811369397758936	1	2	11	2461	8817	0.705268746681658
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	 18	1	1	0	18	2463	8810	0
